Upcoming Discipline Hearings

Due to the COVID-19 pandemic, there are no in-person Discipline Committee proceedings until further notice. Hearings are being re-scheduled in alternative formats (that is, electronic or written proceedings). The schedule below is therefore subject to change.

Please refer to the Discipline Committee’s Direction respecting Electronic and Written Proceedings for further information.

The College will endeavour to ensure that Discipline Committee hearings held by alternative means are nonetheless accessible to the public, unless otherwise stated. If you plan to attend, or for further information, please e-mail hearingsoffice@ocpinfo.com or phone 1-416-962-4861.

The College is committed to supporting accessibility and providing accessible formats and communication supports for persons with disabilities. If you would like to attend a discipline hearing and require accommodations, please contact us at accessibility@ocpinfo.com to make appropriate arrangements.

Hearing Dates: September 29, 2020,

Summary of Allegations

As a result of a referral by the Inquiries, Complaints and Reports Committee, it is alleged that Ewa Polak, while practising pharmacy as Designated Manager and/or dispensing pharmacist at First Place Pharmacy in Mississauga, Ontario, in the period from about January 1, 2015 to November 30, 2016, committed professional misconduct in that she:

  • Failed to exercise appropriate professional diligence with respect to the dispensing of narcotics, which resulted in her filling forged prescriptions purportedly written by Dr. [Name] without making appropriate inquiries;
  • Failed to exercise appropriate professional diligence with respect to the dispensing of narcotics, which resulted in her filling prescriptions for Oxycodone CR 40 and 80mg in doses and/or quantities that were clinically questionable, without taking or documenting any steps to assess the propriety of the prescription.

In particular, it is alleged that she:

  • Failed to maintain a standard of practice of the profession;
  • Contravened the Act, the Drug and Pharmacies Regulation Act, the Regulated Health Professions Act, 1991, or the regulations under those Acts, and in particular, section 155 of the Drug and Pharmacies Regulation Act, R.S.O. 1990, c. H.4, as amended, and/or section 40 of O.Reg. 58/11, R.S.O. 1990, c.H.4;
  • Contravened a federal or provincial law or municipal by-law with respect to the distribution, sale or dispensing of any drug or mixture of drugs, and in particular, section 31 of the Narcotic Control Regulations, C.R.C., c.1041, as amended, under the Controlled Drugs and Substances Act, S.C. 1996, c. 19, as amended;
  • Engaged in conduct or performed an act relevant to the practice of pharmacy that, having regard to all the circumstances, would reasonably be regarded by members of the profession as disgraceful, dishonourable or unprofessional.

 

Hearing Dates: October 1, 2020, October 2, 2020,

Summary of Allegations

As a result of a referral by the Inquiries, Complaints and Reports Committee, it is alleged that Mr. Nasim, while engaged in the practice of pharmacy as dispensing pharmacist, designated manager and/or owner at the MT Cross Pharmacy, Greenhill Pharmacy, and/or I-Care Drug Mart, all in Hamilton, Ontario, committed professional misconduct in that he

  • Submitted (or permitted the submission of) unsubstantiated billings to third party payors, in respect of certain identified products.
  • Failed to keep records as required respecting his patients or practice with respect to certain identified prescriptions.
  • Operated or permitted the MT Cross Pharmacy to operate on or about March 28, 2018, without the supervision of a pharmacist who is physically present.

In particular, it is alleged that he

  • Failed to maintain a standard of practice of the profession
  • Failed to keep records as required respecting his patients or practice
  • Falsified a record in relation to his practice
  • Signed or issued, in his professional capacity, a document he knew or ought to have known contained a false or misleading statement
  • Submitted an account or charge for services or products that he knew or ought to have known was false or misleading
  • Contravened s. 146(1) of the Drug and Pharmacies Regulation Act, R.S.O. 1990, c. H.4
  • Engaged in conduct or performed an act relevant to the practice of pharmacy that, having regard to all the circumstances, would reasonably be regarded by members of the profession as disgraceful, dishonourable or unprofessional

Hearing Dates: October 1, 2020, October 2, 2020,

Summary of Allegations

As a result of a referral by the Inquiries, Complaints and Reports Committee, it is alleged that Mr. Nasim, while engaged in the practice of pharmacy as dispensing pharmacist, designated manager and/or owner at the MT Cross Pharmacy in Hamilton, Ontario, in the period from about June 27, 2017, to May 16, 2018, committed professional misconduct in that he

  • Failed to take all reasonable steps to keep the Pharmacy”™s narcotic and controlled drugs inventory secure against loss and theft;
  • Failed to conduct physical counts and reconciliations of narcotic and controlled drugs inventory as required by the College policy entitled “Medication Procurement and Inventory Management”;
  • Failed to keep adequate records in relation to the Pharmacy”™s inventory of narcotics and controlled drugs;
  • Failed to ensure that delivery slips for deliveries of narcotics and controlled drugs were signed by the patients to whom they were delivered.

In particular, it is alleged that he

  • Failed to maintain a standard of practice of the profession
  • Failed to keep records as required respecting his practice
  • Contravened s. 152(1) of the Drug and Pharmacies Regulation Act, R.S.O. 1990, c. H.4
  • Contravened a federal or provincial law with respect to the distribution, purchase, sale, or dispensing or prescribing of drugs, in particular ss. 30 and 43 of the Narcotic Control Regulations, C.R.C., c. 1041.
  • Engaged in conduct or performed an act relevant to the practice of pharmacy that, having regard to all the circumstances, would reasonably be regarded by members of the profession as disgraceful, dishonourable or unprofessional

Hearing Dates: October 1, 2020, October 2, 2020,

Summary of Allegations

As a result of a referral by the Inquiries, Complaints and Reports Committee, it is alleged that Umair Nasim committed professional misconduct with respect to

  • The finding of guilt made on April 17, 2019 by the Ontario Court of Justice at Hamilton in relation to the following count: that on or about the 16th day of January in the year 2018 at the City of Hamilton, he did contravene sections 30, 42 and 43 of the Narcotic Control Regulations, sections G.03.001(1), G.03.012 and G.03.013 of the Food and Drug Regulations, and sections 7(1)(b) and 50 of the Benzodiazepines and Other Targeted Substances Regulations, thereby committing an offence contrary to section 46 of the Controlled Drugs and Substances Act.

In particular, it is alleged that he

  • Was found guilty of an offence that is relevant to his suitability to practice.

 

Hearing Dates: October 1, 2020, October 2, 2020,

Summary of Allegations

As a result of a referral by the Inquiries, Complaints and Reports Committee, it is alleged that Umair Nasim, while engaged in the practice of pharmacy as dispensing pharmacist, Designated Manager and/or owner at the MT Cross Pharmacy in Hamilton, Ontario, in the period from about June 27, 2017 to May 16, 2018, committed professional misconduct in that he

  • Submitted (or permitted the submission of) unsubstantiated billings to third party payors, in respect of the following products: Apo-Cinacalcet 60mg tablets, Apo-Cinacalcet 90mg tablets, Maxalt 10mg tablets, Maxalt RPD 10mg wafers, and/or Apo-Eletriptan 40mg tablets.

In particular, it is alleged that he

  • Failed to maintain a standard of practice of the profession;
  • Falsified a record in relation to his practice;
  • Signed or issued, in his professional capacity, a document he knew or ought to have known contained a false or misleading statement;
  • Submitted an account or charge for services or products that he knew or ought to have known was false or misleading;
  • Engaged in conduct or performed an act relevant to the practice of pharmacy that, having regard to all the circumstances, would reasonably be regarded by members of the profession as disgraceful, dishonourable or unprofessional.

 

Hearing Dates: October 5, 2020,

Summary of Allegations

As a result of a referral by the Inquiries, Complaints and Reports Committee, it is alleged that Donghyun (Tony) Kim, while employed pharmacist at Sobeys Pharmacy in Oshawa, Ontario, committed professional misconduct in that he:

  • Stole grocery merchandise from Sobeys in Oshawa, Ontario, on or about January 27, 2019, and/or on about January 28, 2019, and/or on or about January 30, 2019, and/or on or about January 31, 2019, and/or on about February 6, 2019.

In particular, it is alleged that he:

  • Engaged in conduct or performed an act relevant to the practice of pharmacy that, having regard to all the circumstances, would reasonably be regarded by members as disgraceful, dishonourable or unprofessional;
  • Engaged in conduct that is unbecoming of a member.

Hearing Dates: October 8, 2020, October 14, 2020, October 15, 2020, October 28, 2020,

Summary of Allegations

As a result of a referral by the Inquiries, Complaints and Reports Committee, it is alleged that Mr. Nasr, while engaged in the practice of pharmacy at Clinic Pharmacy in Midland, committed professional misconduct in that:

  • Between about January 9, 2013 and March 28, 2017, he failed to provide and/or update the Ontario College of Pharmacists with the name, address, telephone number and facsimile number of each person or business for or through which he engaged in the practice of pharmacy;
  • Between about January 9, 2013 and March 28, 2017, he submitted annual renewal certificates and/or information to the College that were/was inaccurate with respect to the name, address, telephone number and facsimile number of each person or business for or through which he engaged in the practice of pharmacy;
  • Between about December 2014 and December 2016, he created (or permitted, consented to or approved, expressly or impliedly, the creation of) false and/or misleading pharmacy records documenting the dispensing of brand name medication when generic medication was dispensed, with respect to certain identified medication;
  • Between about December 2014 and December 2016, he submitted (or permitted, consented to or approved, expressly or impliedly, the submission of) charges for brand name medication when generic medication was dispensed, with respect to certain identified medication;
  • Between about December 2014 and December 2016, he created (or permitted, consented to or approved, expressly or impliedly, the creation of) false and/or misleading pharmacy records documenting the dispensing of drugs and/or products that were not dispensed, with respect to certain identified drugs and/or products;
  • Between about December 2014 and December 2016, he submitted (or permitted, consented to or approved, expressly or impliedly, the submission of) charges for drugs and/or products that were not dispensed, with respect to certain identified drugs and/or products;
  • Between about June 2015 and December 2016, he provided and/or purported to provide routine pharmaceutical care to family members including [family members], and/or including himself as patient;
  • Between about June 2015 and December 2016, he signed certain identified prescription hardcopies as dispensing pharmacist, for ostensible prescriptions for family members including [family members], and/or including himself as patient, but that were not valid prescriptions;
  • Between about June 2015 and December 2016, he created (or permitted, consented to or approved, expressly or impliedly, the creation of) false and/or misleading pharmacy records documenting the selling of certain identified prescription drugs and/or products and/or the processing of prescriptions when those prescriptions were not valid;
  • Between about June 2015 and December 2016, he sold (or permitted, consented to or approved, expressly or impliedly, the sale of) certain identified prescription drugs and/or products without valid prescriptions;
  • Between about June 2015 and December 2016, he submitted (or permitted, consented to or approved, expressly or impliedly, the submission of) charges for certain identified prescription drugs and/or products without valid prescriptions.

In particular, it is alleged that he

  • Failed to maintain a standard of practice of the profession;
  • Falsified a record relating to his practice;
  • Signed or issued in his professional capacity a document that he knew contained a false or misleading statement;
  • Submitted an account or charge for services that he knew was false or misleading;
  • Contravened the Pharmacy Act, 1991, the Drug and Pharmacies Regulation Act, the Regulated Health Professions Act, 1991 or the regulations under those Acts, and in particular:
    • s. 155 of the Drug and Pharmacies Regulation Act, R.S.O. 1990, c. H.4;
  • Contravened a federal or provincial law or municipal by-law with respect to the distribution, sale or dispensing of any drug or mixture of drugs, and in particular:
    • s. 15(1)(b) of the Ontario Drug Benefit Act, R.S.O. 1990, c. O.10;
    • s. 15(1)(b) of the Ontario Drug Benefit Act, R.S.O. 1990, c. O.10;
    • s. C.01.041 of the Food and Drug Regulations, C.R.C. 870, made under the Food and Drugs Act, R.S.C. 1985, c. F-27;
  • Engaged in conduct or performed an act relevant to the practice of pharmacy that, having regard to all the circumstances, would reasonably be regarded by members of the profession as disgraceful, dishonourable or unprofessional.

This hearing commenced on December 11 and 12, 2019.

Hearing Dates: October 19, 2020, October 20, 2020, October 21, 2020, October 22, 2020,

Summary of Allegations

As a result of a referral by the Inquiries, Complaints and Reports Committee, it is alleged that Ms. Czilli, on one or more occasions during the period July 3, 2015 to April 1, 2017, while engaged in the practice of pharmacy as owner, Designated Manager and/or dispensing pharmacist at Wellington Apothecary in Windsor, Ontario, committed professional misconduct in that she

  • Submitted accounts or charges for services that she knew or reasonably ought to have known were false or misleading to the Ontario Drug Benefit program for MedsCheck reviews that were never conducted and/or were non-compliant with the guidelines of the Ministry of Health and Long Term Care;
  • Falsified pharmacy records in relation to claims made to the Ontario Drug Benefit Program for MedsCheck reviews that were never conducted and/or were non-compliant with the guidelines of the Ministry of Health and Long Term Care; and/or,
  • Failed to keep records as required in relation to MedsCheck claims made to the Ontario Drug Benefit Program.

In particular, it is alleged that she

  • Failed to maintain a standard of practice of the profession
  • Falsified records relating to her practice
  • Signed or issued, in her professional capacity, a document that she knew contained a false or misleading statement
  • Submitted an account or charge for services that she knew was false or misleading statement
  • Contravened the Act, the Drug and Pharmacies Regulation Act, the Regulated Health Professions Act, 1991, or the regulations under those Acts, and in particular sections 20 and 21 of Ontario Regulation 264/16
  • Failed to keep records as required
  • Engaged in conduct or performed an act or acts relevant to the practice of pharmacy that, having regard to all the circumstances, would reasonably be regarded by members of the profession as disgraceful, dishonourable or unprofessional

Hearing Dates: October 27, 2020,

Summary of Allegations

As a result of a referral by the Inquiries, Complaints and Reports Committee, it is alleged that Thi Vuong, while engaged in the practice of pharmacy as director, shareholder, owner, designated manager, and/or dispensing pharmacist at Pacific Pharmacy Mississauga (the “Pharmacy”) in Mississauga, Ontario, committed professional misconduct in that she:

  • Dispensed and/or billed for drugs and/or products without a prescription authorized by a prescriber for one or more of certain identified drugs and/or products from in or about January 2017 to in or about December 2017;
  • Failed to keep records as required respecting her patients and/or practice with respect to one or more of certain identified drugs and/or products from in or about January 2017 to in or about December 2017;
  • Falsified a record relating to her practice and/or a person’s health record with respect to one or more of certain identified drugs and/or products from in or about January 2017 to in or about December 2017;
  • Signed or issued, in her professional capacity, a document that she knew or ought to have known contained a false or misleading statement with respect to one or more of certain identified drugs and/or products from in or about January 2017 to in or about December 2017; and/or
  • Submitted an account or charge for services that she knew or ought to have known was false or misleading with respect to one or more of certain identified drugs and/or products from in or about January 2017 to in or about December 2017.

In particular, it is alleged that she:

  • Failed to maintain a standard of practice of the profession;
  • Failed to keep records as required respecting her patients and/or practice;
  • Falsified a record relating to her practice and/or a person’s health record;
  • Signed or issued, in her professional capacity, a document that she knew and/or ought to have known contained a false or misleading statement;
  • Submitted an account or charge for services or products that she knew and/or ought to have known was false or misleading;
  • Contravened the Pharmacy Act, 1991, the Drug and Pharmacies Regulation Act, the Regulated Health Professions Act, 1991, the Narcotics Safety and Awareness Act, 2010, the Drug Interchangeability and Dispensing Fee Act or the Ontario Drug Benefit Act or the regulations under those Acts, and in particular:
    • sections 155, 163, and 166 of the Drug and Pharmacies Regulation Act and section 20 of Ontario Regulation 264/16;
  • Contravened a federal, provincial or territorial law with respect to the distribution, sale or dispensing of any drug or mixture of drugs, with respect to the distribution, purchase, sale, dispensing or prescribing of any drug or product, the administering of any substance, or the piercing of the dermis, whose purpose is to protect or promote the public health, and/or that is otherwise relevant to her suitability to practise, and in particular:
    • sections 155, 163, and 166 of the Drug and Pharmacies Regulation Act and section 20 of Ontario Regulation 264/16;
  • Engaged in conduct or performed an act relevant to the practice of pharmacy that, having regard to all the circumstances, would reasonably be regarded by members as disgraceful, dishonourable or unprofessional.

Hearing Dates: November 3, 2020, November 13, 2020,

Summary of Allegations

Following a hearing on February 11-15, 2019, a Panel of the Discipline Committee made findings of professional misconduct against Ms. Bijanzadeh in a decision dated September 17, 2019, in that she:

  • Failed to exercise appropriate professional diligence with respect to the dispensing of narcotics, which resulted in her filling forged prescriptions purportedly written by [Physician A]. and/or [Physician B] without making appropriate inquiries.

In particular, the Panel found that she

  • Failed to maintain a standard of practice of the profession;
  • Contravened the Act, the Drug and Pharmacies Regulation Act, the Regulated Health Professions Act, 1991, or the regulations under those Acts, and in particular, section 155 of the Drug and Pharmacies Regulation Act, R.S.O. 1990, c. H.4, as amended, and/or section 40 of O.Reg. 58/11, R.S.O. 1990, c.H.4;
  • Contravened a federal or provincial law or municipal by-law with respect to the distribution, sale or dispensing of any drug or mixture of drugs, and in particular, section 31 of the Narcotic Control Regulations, C.R.C., c.1041, as amended, under the Controlled Drugs and Substances Act, S.C. 1996, c. 19, as amended;
  • Engaged in conduct or performed an act relevant to the practice of pharmacy that, having regard to all the circumstances, would reasonably be regarded by members of the profession as dishonourable and unprofessional.

Submissions with respect to Order will be heard on November 3 and 13, 2020.

Hearing Dates: November 23, 2020,

Summary of Allegations

As a result of a referral by the Inquiries, Complaints and Reports Committee, it is alleged that Mr. Lin, while engaged in the practice of pharmacy as owner and/or dispensing pharmacist at the Life Compounding Pharmacy in Richmond Hill, Ontario, in or about the period from December 5, 2016 to December 31, 2018, committed professional misconduct in that he

  • Conducted sterile compounding of atropine eye drops at a facility not accredited for that purpose;
  • Kept products in the compounding area that were expired and/or not properly labelled;
  • Failed to keep the compounding area in an acceptable state of cleanliness and organization;
  • Failed to keep records as required in respect of certain identified cancelled prescriptions.

In particular, it is alleged that he

  • Failed to maintain a standard of practice of the profession;
  • Contravened sections 139 and 146 of the Drug and Pharmacies Regulation Act, R.S.O. 1990, c. H.4;
  • Engaged in conduct or performed an act or acts relevant to the practice of pharmacy that, having regard to all the circumstances, would reasonably be regarded by members of the profession as disgraceful, dishonourable or unprofessional.

 

Hearing Dates: December 2, 2020, December 3, 2020,

Summary of Allegations

As a result of a referral by the Inquiries, Complaints and Reports Committee, it is alleged that Ms. Mourid, while engaged in the practice of pharmacy as director, shareholder, Designated Manager and/or dispensing pharmacist at St. Mary Pharmacy, Ontario (“the Pharmacy”) committed professional misconduct in that she

  • Submitted and/or permitted, consented to or approved, either expressly or by implication, the submission of, accounts or charges for services that she knew were false or misleading to the Ontario Drug Benefit program through the Pharmacy for:
      1. one or more of certain identified drugs and/or products from on or about September 1, 2014 on or about August 31, 2016,
      2. one or more of certain identified MedsCheck reviews submitted from on or about August 23, 2012 to on or about August 23, 2016, which were non-compliant with the guidelines of the Ministry of Health and Long Term Care;
      3. one or more of certain identified chronic use medications submitted on or after October 1, 2015, with respect to which there was missing and/or incomplete frequent dispensing documentation;
      4. one or more influenza vaccines administered to ineligible patients under the age of 18 and /or with respect to which there was missing documentation, including RX# 117551, 152333, 153737 and/or 154095;
      5. one or more of certain identified “Limited Use” products, which did not meet the clinical criteria for reimbursement specified in the Ontario Drug Benefit Formulary;
      6. one or more prescriptions for deceased patients, includingRX# 137062, 159995, 160004, 160030, 160031, 160102, 160103, 160104, 160105 and/or 160106;
      7. one or more invalid extemporaneous preparations, including RX# 123305, 124635, 133807, 152568, 156687 and/or 173912;
      8. one or more of certain identified transactions, in which the patient”™s Ontario Drug Benefit eligibility card was not obtained or retained by the Pharmacy, and/or
      9. one or more nutritional products, including RX# 113182, 119926, 122722, 126487, 133094, 137417, 144737, 147421, 156605, 159973, 164544, 169389, 172746, 175796 and/or 184969 for a patient who did not meet the eligibility criteria specified in the Ontario Drug Benefit Formulary;
  • Falsified and/or permitted, consented to or approved, either expressly or by implication, the falsification of pharmacy records relating to her practice in relation to the dispensing of and/or claims made to the Ontario Drug Benefit program through the Pharmacy for:
      1. one or more of certain identified drugs and/or products from on or about September 1, 2014 on or about August 31, 2016,
      2. one or more of certain identified MedsCheck reviews submitted from on or about August 23, 2012 to on or about August 23, 2016, which were non-compliant with the guidelines of the Ministry of Health and Long Term Care;
      3. one or more of certain identified chronic use medications submitted on or after October 1, 2015, with respect to which there was missing and/or incomplete frequent dispensing documentation;
      4. one or more influenza vaccines administered to ineligible patients under the age of 18 and /or with respect to which there was missing documentation, including RX# 117551, 152333, 153737 and/or 154095;
      5. one or more of certain identified “Limited Use” products, which did not meet the clinical criteria for reimbursement specified in the Ontario Drug Benefit Formulary;
      6. one or more prescriptions for deceased patients, includingRX# 137062, 159995, 160004, 160030, 160031, 160102, 160103, 160104, 160105 and/or 160106;
      7. one or more invalid extemporaneous preparations, including RX# 123305, 124635, 133807, 152568, 156687 and/or 173912;
      8. one or more of certain identified transactions, in which the patient”™s Ontario Drug Benefit eligibility card was not obtained or retained by the Pharmacy, and/or
      9. one or more nutritional products, including RX# 113182, 119926, 122722, 126487, 133094, 137417, 144737, 147421, 156605, 159973, 164544, 169389, 172746, 175796 and/or 184969 for a patient who did not meet the eligibility criteria specified in the Ontario Drug Benefit Formulary;
  • Failed to ensure that the Pharmacy complied with all legal requirements, including but not limited to, requirements regarding record keeping, documentation, and billing the Ontario Drug Benefit Plan.
  • Failed to keep records of monthly Ontario Drug Benefit eligibility cards or a copy of the cards with respect to each person for whom a drug was dispensed, as required by section 29 of Ontario Regulation 201/96, under the Ontario Drug Benefits Act, R.S.O. 1990, c. O.10, as amended, from on or about October, 2014 to on or about June, 2016
  • Submitted to the Ontario College of Pharmacists and/or the Ministry of Health and Long Term Care invoices, receipts and/or other documentation that she knew, or ought to have known, was false, misleading or unreliable to substantiate the purchase and/or transfer of one or more of certain identified drugs and/or products

In particular, it is alleged that she

  • Failed to maintain a standard of practice of the profession
  • Failed to keep records as required respecting her patients
  • Falsified and/or permitted, consented to or approved, either expressly or by implication, the falsification of records relating to her practice
  • Signed or issued, in her professional capacity, and/or permitted, consented to or approved, either expressly or by implication, the signing or issuing of a document that she knew contained a false or misleading statement
  • Submitted and/or permitted, consented to or approved the submission of accounts or charges for services that she knew to be false or misleading
  • Contravened the Pharmacy Act,1991, the Drug and Pharmacies Regulation Act, the Regulated Health Professions Act, 1991 or the regulations under those Acts and in particular:
    1. Sections 155 and 156 of the Drug and Pharmacies Regulation Act, R.S.O. 1990, c. H-4, as amended
  • Contravened a federal or provincial law or municipal by-law with respect to the distribution, sale or dispensing of any drug or mixture of drugs, and in particular:
    1. Sections 5, 6, 15(1)(b)and/or 17(2) of the Ontario Drug Benefits Act, R.S.O. 1990, c. O.10, as amended, and/or Ontario Regulation 201/96 made thereunder
    2. Sections 155 and 156 of the Drug and Pharmacies Regulation Act, R.S.O. 1990, c. H-4, as amended
  • Permitted, consented to or approved, either expressly or by implication, the contravention of a federal or provincial law or municipal by-law with respect to the distribution, sale or dispensing of any drug or mixture of drugs, and in particular:
    1. Sections 5, 6, 15(1)(b)and/or 17(2) of the Ontario Drug Benefits Act, R.S.O. 1990, c. O.10, as amended, and/or Ontario Regulation 201/96 made thereunder
    2. Sections 155 and 156 of the Drug and Pharmacies Regulation Act, R.S.O. 1990, c. H-4, as amended
  • Engaged in conduct or performed an act or acts relevant to the practice of pharmacy that, having regarding to all the circumstances, would reasonably be regarded by members of the profession as disgraceful, dishonourable or unprofessional

This hearing commenced on July 22, 2020.

Hearing Dates: TBA

Summary of Allegations

As a result of a referral by the Inquiries, Complaints and Reports Committee, it is alleged that Ms. Abanzukwe committed professional misconduct in that she:

  • Failed to fulfill all requirements related to working with a practice mentor, as ordered by the Discipline Committee on December 8, 2016.

In particular, it is alleged that she

  • Contravened a term, condition or limitation imposed on her certificate of registration;
  • Failed to comply with an order of a panel of a Committee of the College;
  • Engaged in conduct or performed acts that, having regard to all the circumstances, would reasonably be regarded by members of the profession as unprofessional, dishonourable or disgraceful.

Hearing Dates: TBA

Summary of Allegations

As a result of a referral by the Inquiries, Complaints and Reports Committee, it is alleged that Ms. Abanzukwe, while practising as a pharmacist, Designated Manager and/or the sole director and shareholder of the corporation that owned and operated Brock Medical Pharmacy at 1637 Dundas Street West in Toronto, Ontario, committed professional misconduct in that she

  • Engaged in the practice of pharmacy while her certificate was suspended from on or around December 1, 2018 to on or around January 31, 2019;
  • Falsified records relating to her practice or a person’s health record with respect to one or more identified prescriptions from on or about December 1, 2018 to on or about January 31, 2019;
  • Kept medications in inventory without expiration dates and/or lot numbers, in or around February of 2019.

In particular, it is alleged that she

  • Contravened a term, condition or limitation imposed on her certificate of registration;
  • Failed to comply with an order of a panel of a Committee of the College;
  • Practised the profession while her certificate was under suspension;
  • Falsified records relating to her practice or a person’s health record;
  • Failed to maintain a standard of practice of the profession;
  • Engaged in conduct or performed acts that, having regard to all the circumstances, would reasonably be regarded by members of the profession as unprofessional, dishonourable or disgraceful.

Hearing Dates: TBA

Summary of Allegations

As a result of a referral by the Inquiries, Complaints and Reports Committee, it is alleged that Joy Abanzukwe, as a dispensing pharmacist and/or Designated Manager at Remedy’s Rx Brock Medical Pharmacy at 1637 Dundas Street West in Toronto, Ontario (the Pharmacy), and/or as the director and/or sole shareholder of the corporation that owned the Pharmacy, committed professional misconduct with respect to the following:

  • False or unsubstantiated claims submitted to the Ontario Drug Benefit Program (ODB) from the Pharmacy totalling approximately $103,932 for 20 identified drug and other health products, from on or around July 1, 2015 to on or around August 31, 2017; and/or
  • Improper claims for prescriptions submitted to the ODB from the Pharmacy totalling approximately $19,485, in relation to one or more of certain identified claims.

In particular, it is alleged that she:

  • Failed to maintain a standard of the profession;
  • Contravened, while engaged in the practice of pharmacy, a federal or provincial law or municipal by-law with respect to the distribution, sale or dispensing of any drug or mixture of drugs, and in particular:
    • sections 5, 15, 17 and/or 23 of the Ontario Drug Benefit Act; and/or
    • sections 25 and/or 27 of Ontario Regulation 201/96; and/or
    • sections 155, 156, 163 and/or 166 of the Drug and Pharmacies Regulation Act;
  • Failed to keep records as required respecting her patients;
  • Submitted an account or charge for services that she knew and/or ought to have known was false or misleading;
  • Falsified a record relating to her practice;
  • Signed or issued, in her professional capacity, a document she knew or ought to have known contained a false or misleading statement;
  • Engaged in conduct or performed an act relevant to the practice of pharmacy that, having regard to all the circumstances, would reasonably be regarded by members as disgraceful, dishonourable or unprofessional.

Hearing Dates: TBA

Summary of Allegations

As a result of a referral by the Accreditation Committee, it is alleged that 2037424 Ontario Inc., to whom the certificate of accreditation for Brock Medical Pharmacy was issued, and Joy Abanzukwe, the sole director of 2037424 Ontario Inc. and the Designated Manager of Brock Medical Pharmacy, committed an act or acts of proprietary misconduct by refilling, selling and/or renewing prescription drugs without a prescription, between in or around April 11, 2019 and July 17, 2019.

In particular, it is alleged that 2037424 Ontario Inc., to whom the certificate of accreditation for Brock Medical Pharmacy was issued, and Joy Abanzukwe, the sole director of 2037424 Ontario Inc. and the Designated Manager of Brock Medical Pharmacy:

  • Contravened the Drug and Pharmacies Regulation Act, the Pharmacy Act, 1991, the Regulated Health Professions Act, 1991, the Narcotics Safety and Awareness Act, 2010, the Drug Interchangeability and Dispensing Fee Act, the Ontario Drug Benefits Act or the regulations under those Acts, including but not limited to section 155 of the Drug and Pharmacies Regulation Act;
  • Contravened a federal, provincial or territorial law or any municipal by-law, with respect to the distribution, purchase, sale, dispensing or prescribing of any drug product, the administering of any substance or the piercing of the dermis, where the purpose of the law or by-law is to protect or promote public health, or where the law or bylaw relates to the operation of the pharmacy or the provision of pharmacy services, including but not limited to subsection C.01.041(1)(a) of the Food and Drug Regulations, C.R.C., c. 870, as amended; and
  • Engaged in conduct or performed an act relevant to the operation of a pharmacy that, having regard to the circumstances, would reasonably be regarded by members as disgraceful, dishonourable or unprofessional.

Hearing Dates: TBA

Summary of Allegations

As a result of a referral by the Inquiries, Complaints and Reports Committee, it is alleged that Rami Abdelmalek, while engaged in the practice of pharmacy as owner, director, shareholder, and/or dispensing pharmacist at Westboro Pharmasave in Ottawa, Ontario, committed professional misconduct in that he:

  • Submitted (or permitted, consented to, or approved, expressly or by implication, the submissions of) claims with excessive markups for one or more of certain identified drugs and/or products from in or about November 1, 2016 to in or about April 30, 2018;
  • Submitted (or permitted, consented to, or approved, expressly or by implication, the submissions of) claims to multiple plans where one or more of those plans was not obligated to pay the claim (or the full amount of the claim) for one or more of certain identified drugs and/or products from in or about November 1, 2016 to in or about April 30, 2018; and/or
  • Submitted (or permitted, consented to or approved, expressly or by implication, the submissions of) claims for dispensing fees for compliance packages at more frequent intervals than the compliance packages were being dispensed for one or more patients from in or about May 1, 2018 to in or about April 24, 2019.

In particular, it is alleged that he:

  • Failed to maintain a standard of practice of the profession;
  • Failed to keep records as required respecting his patients and/or practice;
  • Falsified a record relating to his practice and/or a person’s health record;
  • Signed and/or issued, in his professional capacity, a document that he knew and/or ought to have known contained a false and/or misleading;
  • Submitted an account and/or charge for services and/or products that he knew and/or ought to have known was false and/or misleading;
  • Charged (or permitted, consented to, or approved, expressly or by implication, charges for) a fee and/or amount that was excessive in relation to the service and/or product provided;
  • Engaged in conduct or performed an act relevant to the practice of pharmacy that, having regard to all the circumstances, would reasonably be regarded by members as disgraceful, dishonourable and/or unprofessional.

Hearing Dates: TBA

Summary of Allegations

As a result of a referral by the Inquiries, Complaints and Reports Committee, it is alleged that Rami Abdelmalek, in response to an investigation by the Ontario College of Pharmacists (the “College”) into his conduct at Westboro Pharmasave in Ottawa, Ontario committed professional misconduct, in that he:

  • Provided falsified employment records and/or other pharmacy records to the College;
  • Provided false and/or misleading information to the College in written submissions, emails, and/or other correspondence; and/or
  • Refused to provide relevant documents to College investigators upon request.

In particular, it is alleged that he:

  • Contravened the Regulated Health Professions Act, 1991, as amended, and in particular:
    • Subsections 76(3) and 76(3.1) of the Health Professions Procedural Code to the Regulated Health Professions Act, 1991;
  • Engaged in conduct or performed an act relevant to the practice of pharmacy that, having regard to all the circumstances, would reasonably be regarded by members as disgraceful, dishonourable and/or unprofessional.

Hearing Dates: TBA

Summary of Allegations

As a result of a referral by the Inquiries, Complaints and Reports Committee, it is alleged that Mr. Abdou, as a pharmacist at Martindale IDA Pharmacy in St. Catharines, Ontario, and/or as director of the corporation that owns and operates the Pharmacy, committed professional misconduct in that he

  • Submitted claims to [Insurance Claims Adjudicator] that included markups on the unit drug cost that were excessive and unreasonable, in or about March 2017-March 2018

In particular, it is alleged that he

  • Failed to maintain a standard of practice of the profession
  • Charged a fee that was excessive in relation to the service provided
  • Charged a fee or amount that was excessive in relation to the service or product provided
  • Engaged in conduct or performed an act relevant to the practice of pharmacy that, having regard to all the circumstances, would reasonably be regarded by members as disgraceful, dishonourable or unprofessional

Hearing Dates: TBA

Summary of Allegations

As a result of a referral by the Inquiries, Complaints and Reports Committee, it is alleged that Murad Al Hasan, as pharmacist and Designated Manager at Med RX Altabank Pharmacy (the Pharmacy), in Ontario, and/or as director of the corporation that owns and operates the Pharmacy, committed professional misconduct in that he:

  • Transmitted false electronic claims to [Insurance Claims Adjudicator] in respect of a Pharmacy patient, [Patient], from on or about August 18, 2017, to on or about January 28, 2019.

In particular, it is alleged that he:

  • Failed to maintain a standard of practice of the profession;
  • Falsified a record related to his practice or a person’s health record;
  • Signed or issued in his professional capacity, a document that he knew or ought to have known contained a false a misleading or statement;
  • Submitted an account or charge for services or products that he knew or ought to have known was false or misleading;
  • Engaged in conduct or performed an act relevant to the practice of pharmacy that, having regard to all the circumstances, would reasonably be regarded by members as disgraceful, dishonourable or unprofessional.

Hearing Dates: TBA

Summary of Allegations

As a result of a referral by the Inquiries, Complaints and Reports Committee, it is alleged that Nekpen Asemota, as pharmacist and Designated Manager at Shoppers Drug Mart, located at 1675 Wyandotte Street West, in Windsor, Ontario (the Pharmacy), and/or as director and/or shareholder of the corporation that owns and operates the Pharmacy, committed professional misconduct in that she:

  • Failed to ensure that the Pharmacy had adequate protocols and policies in place to verify the contents of compliance package medication dispensed from the Pharmacy, from on or about January 2018, to on or about November 20, 2018;
  • Failed to ensure the Pharmacy had adequate protocols and policies in place to record and reconcile medication inventory, including medication that had been returned to stock from compliance packages, from on or about January 2018, to on or about November 20, 2018;
  • Failed to complete inventory reconciliations for narcotics and other controlled drugs at least every six months, and/or failed to retain records of such inventory reconciliations, from on or about May 5, 2017, to on or about November 20, 2018;
  • Maintained incomplete and/or inaccurate records with respect to compliance pack medication for certain identified patients, from on or about January 2018, to on or about November 20, 2018;
  • Billed for the dispensing of medication in compliance aids to patients on dates when compliance aids were not dispensed, with respect to certain identified patients, from on or about January 2018, to on or about October 2018;
  • Permitted, consented to or approved, either expressly or by implication, an unregistered Pharmacy assistant to bear a name-tag falsely identifying her with the protected title “Pharmacy Technician”, on or about November 20, 2018.

In particular, it is alleged that she:

  • Failed to maintain a standard of practice of the profession;
  • Failed to keep records as required respecting her patients or practice;
  • Falsified a record related to her practice or a person’s health record;
  • Signed or issued in her professional capacity, a document that she knew or ought to have known contained a false a misleading or statement;
  • Submitted an account or charge for services or products that she knew or ought to have known was false or misleading;
  • Engaged in conduct or performed an act relevant to the practice of pharmacy that, having regard to all the circumstances, would reasonably be regarded by members as disgraceful, dishonourable or unprofessional.

Hearing Dates: TBA

Summary of Allegations

As a result of a referral by the Inquiries, Complaints and Reports Committee, it is alleged that Ms. Awad, while engaged in the practice of pharmacy as director, shareholder, owner, designated manager, and/or dispensing pharmacist at John Garland Pharmacy (the “Pharmacy”) in Etobicoke, Ontario, committed professional misconduct in that she

  • Failed to keep records as required respecting her patients and/or practice with respect to one or more of certain identified drugs and/or products from in or about January 2015 to in or about September 2017;
  • Falsified a record relating to her practice and/or a person’s health record with respect to one or more of certain identified drugs and/or products from in or about January 2015 to in or about September 2017;
  • Signed or issued, in her professional capacity, a document that she knew or ought to have known contained a false or misleading statement with respect to one or more of certain identified drugs and/or products from in or about January 2015 to in or about September 2017; and/or
  • Submitted an account or charge for services that she knew or ought to have known was false and misleading with respect to one or more of certain identified drugs and/or products from in or about January 2015 to in or about September 2017.

In particular, it is alleged that she

  • Failed to maintain a standard of practice of the profession
  • Failed to keep records as required respecting her patients and/or practice
  • Falsified a record relating to her practice and/or a person’s health record
  • Signed or issued, in her professional capacity, a document that she knew and/or ought to have known contained a false or misleading statement
  • Submitted an account or charge for services or products that she knew and/or ought to have known was false or misleading
  • Contravened the Pharmacy Act, 1991, the Drug and Pharmacies Regulation Act, the Regulated Health Professions Act, 1991, the Narcotics Safety and Awareness Act, 2010, the Drug Interchangeability and Dispensing Fee Act or the Ontario Drug Benefit Act or the regulations under those Acts, and in particular:
    1. sections 155(1), 156, 163, and 166 of the Drug and Pharmacies Regulation Act, section 20(1) of Ontario Regulation 264/16, and sections 40(1) and 54(1) of Ontario Regulation 58/11
  • Contravened a federal, provincial or territorial law with respect to the distribution, sale or dispensing of any drug or mixture of drugs, with respect to the distribution, purchase, sale, dispensing or prescribing of any drug or product, the administering of any substance, or the piercing of the dermis, whose purpose is to protect or promote the public health, and/or that is otherwise relevant to her suitability to practise, and in particular:
    1. sections 155(1), 156, 163, and 166 of the Drug and Pharmacies Regulation Act, section 20(1) of Ontario Regulation 264/16, and sections 40 and 54(1) of Ontario Regulation 58/11
    2. sections 5, 6, and 15(1) of the Ontario Drug Benefit Act and section 27 of Ontario Regulation 201/96
  • Engaged in conduct or performed an act relevant to the practice of pharmacy that, having regard to all the circumstances, would reasonably be regarded by members as disgraceful, dishonourable or unprofessional

Hearing Dates: TBA

Summary of Allegations

As a result of a referral by the Inquiries, Complaints and Reports Committee, it is alleged that Pedro Barreiro, as Designated Manager and sole director and shareholder of the corporation that owned and operated Shoppers Drug Mart, located on 1821 Robertson Road in Ottawa, Ontario, committed professional misconduct in that he:

  • Maintained prescription hardcopies that were missing pharmacist signatures in respect of approximately 1267 transactions, from on or about 2015, to on or about September 10, 2018; and/or
  • Completed pharmacist-authorized prescription renewals for controlled substances that he did not have the authority to renew in respect of approximately 48 transactions, from on or about January 1, 2017, to on or about September 7, 2018; and/or
  • Completed pharmacist-authorized prescription renewals for which he maintained incomplete or insufficient documentation in respect of approximately 352 transactions, from on or about July 22, 2016, to on or about June 21, 2018; and/or
  • Submitted bills for MedsChecks transactions which he did not complete in respect of:
    1. 44 MedsChecks billed on September 26, 2016; and/or
    2. 28 MedsChecks billed on September 30, 2016; and/or
    3. 26 MedsChecks billed on December 28, 2017; and/or
  • Failed to properly maintain MedsChecks documentation as required in respect of:
    1. 44 transactions billed on or about September 26, 2016; and/or
    2. 28 transactions billed on or about September 30, 2016; and/or
    3. 26 transactions billed on or about December 28, 2017; and/or
    4. 40 transactions billed from on or about February 17, 2017, to on or about August 11, 2018; and/or
    5. 12 MedsChecks Patient Acknowledgement Forms which were inaccurately dated or undated; and/or
  • Failed to document notification of, and/or notify patients’ primary care providers as required, with respect to 51 MedsChecks transactions, from on or about October 1, 2016, to on or about September 10, 2018; and/or
  • Failed to document notification of, and/or notify patients’ prescribers as required, with respect to 403 pharmacist-authorized prescription renewals, from on or about January 1, 2016, to on or about September 10, 2018; and/or
  • Failed to document notification of, and/or notify the prescriber of patient [Name], as required, with respect to 18 pharmacist-authorized prescription renewals, from on or about December 4, 2017, to on or about April 2, 2018.

In particular, it is alleged that he:

  • Failed to maintain a standard of practice of the profession;
  • Failed to keep records as required respecting his patients;
  • Falsified a record related to his practice or a person’s health record;
  • Signed or issued, in his professional capacity, a document that he knew or ought to have known contained a false or misleading statement;
  • Submitted an account or charge for services or products that he knew or ought to have known was false or misleading;
  • Engaged in conduct or performed an act relevant to the practice of pharmacy that, having regard to all the circumstances, would reasonably be regarded by members as disgraceful, dishonourable or unprofessional.

Hearing Dates: TBA

Summary of Allegations

As a result of a referral by the Inquiries, Complaints and Reports Committee, it is alleged that Pedro Barreiro, committed professional misconduct in that he:

  • Failed to report to the College that he had been charged with a criminal offence (having care and control of a motor vehicle while “over 80”, contrary to section 253(1)(b) of the Criminal Code) on May 22, 2013, and/or that he had been convicted of that offence on May 29, 2014;
  • On his annual renewal form submitted on or about March 5, 2014, he falsely answered “no” on his 2014 College Annual Renewal Form, to the question “are you the subject of a current proceeding in respect of any offence in any jurisdiction?”; and/or on his annual renewal form submitted on or about March 9, 2015, he falsely answered “no” on no 2015 College Annual Renewal Form, to the question “since your last declaration to the College, have you been found guilty of any offence in any jurisdiction?”

In particular, it is alleged that he:

  • Contravened a term, condition or limitation imposed on his certificate of registration;
  • Signed or issued, in his professional capacity, a document that the he knew contained a false or misleading statement;
  • Engaged in conduct or performed an act relevant to the practice of pharmacy that, having regard to all the circumstances, would reasonably be regarded by members as disgraceful, dishonourable or unprofessional.

Hearing Dates: TBA

Summary of Allegations

As a result of a referral by the Inquiries, Complaints and Reports Committee, it is alleged that Leisa Barrett, while practicing pharmacy as Designated Manager, sole director and shareholder, and/or dispensing pharmacist at The Medicine Shoppe (the “Pharmacy”), in the period from about April 2017 to January 2019, while engaged in the practice of pharmacy in the Province of Ontario, committed professional misconduct in that she:

  • Failed to keep records as required by the Medication Procurement and Inventory Management Policy with respect to the inventory of narcotics and controlled drugs, including with respect to controlled substances used in compounding and expired and patient-returned substances;
  • Failed to maintain security of narcotics and other controlled drugs, specifically with respect to expired and patient-returned medications;
  • Failed to maintain accurate records of purchases, sales and remaining inventory for narcotics and other controlled drugs; and/or
  • Failed to make timely reports of losses of narcotics and other controlled drugs to Health Canada, specifically with respect to reconciliations conducted in 2018.

In particular, it is alleged that she:

  • Failed to maintain a standard of practice of the profession;
  • Failed to keep records as required;
  • Contravened a federal or provincial law or municipal by-law with respect to the distribution, sale or dispensing of any drug or mixture of drugs, including:
    • the Narcotic Control Regulations, sections 40, 42 and/or 43, under the Controlled Drugs and Substances Act, S.C. 1996, c. 19; and/or
    • the Food and Drug Regulations, sections G.03.010, G.03.012, G.03.013 and/or G.03.015, under the Food and Drugs Act, R.S.C. 1985 c.F-27; and/or
    • ss. 72 and 75 of the Benzodiazepines and Other Targeted Substances Regulation;
  • Engaged in conduct or performed an act relevant to the practice of pharmacy that, having regard to all the circumstances, would reasonably be regarded by members of the profession as disgraceful, dishonourable or unprofessional.

Hearing Dates: TBA

Summary of Allegations

As a result of a referral by the Inquiries, Complaints and Reports Committee, it is alleged that Sameet Bawa, while engaged in the practice of pharmacy as dispensing pharmacist, Designated Manager, shareholder and/or director at The Pharmacy Network in Toronto, Mississauga and/or Orangeville, from about January 1, 2017 to December 31, 2017, committed professional misconduct in that he:

  • Submitted false claims for one or more of certain identified drugs and other products that were not actually dispensed to patients;
  • Falsified records in respect of certain identified prescriptions.

In particular, it is alleged that he:

  • Failed to maintain the standards of practice of the profession;
  • Falsified records relating to his practice;
  • Signed or issued, in his professional capacity, a document that he knew or ought to have known contained a false or misleading statement;
  • Submitted an account or charge for services or products that he knew or ought to have known was false or misleading;
  • Contravened the Pharmacy Act, the Drug and Pharmacies Regulation Act, the Regulated Health Professions Act, 1991, or the regulations under those Acts, and in particular:
    • s. 155 of the Drug and Pharmacies Regulation Act, R.S.O. 1990, c. H-4, as amended;
  • Contravened a federal or provincial law or municipal by-law with respect to the distribution, sale or dispensing of any drug or mixture of drugs, and in particular:
    • ss. 5 and 15(1) of the Ontario Drug Benefit Act, R.S.O. 1990, c. O.10, as amended;
  • Permitted, consented to, approved, counselled or assisted, whether expressly or by implication, the commission of an offence against any Act relating to the practice of pharmacy or the sale of drugs, and in particular:
    • ss. 155 and 165 of the Drug and Pharmacies Regulation Act, R.S.O. 1990, c. H-4, as amended;
  • Engaged in conduct or performed an act relevant to the practice of pharmacy that, having regard to all the circumstances, would reasonably be regarded by members of the profession as disgraceful, dishonourable or unprofessional.

Hearing Dates: TBA

Summary of Allegations

As a result of a referral by the Inquiries, Complaints and Reports Committee, it is alleged that Andrew Besada, while engaged in the practice of pharmacy as dispensing pharmacist, Designated Manager, shareholder and/or director at Central Weston Pharmacy in Toronto, Ontario, from about March 1, 2016 to July 23, 2019, committed professional misconduct in that he:

  • Submitted false claims for one or more of certain identified drugs and other products that were not actually dispensed to patients.

In particular, it is alleged that he:

  • Failed to maintain the standards of practice of the profession;
  • Falsified records relating to his practice;
  • Signed or issued, in his professional capacity, a document that he knew or ought to have known contained a false or misleading statement;
  • Submitted an account or charge for services or products that he knew or ought to have known was false or misleading;
  • Contravened the Pharmacy Act, the Drug and Pharmacies Regulation Act, the Regulated Health Professions Act, 1991, or the regulations under those Acts, and in particular, ss. 155 and 156 of the Drug and Pharmacies Regulation Act, R.S.O. 1990, c. H-4, as amended;
  • Contravened a federal or provincial law or municipal by-law with respect to the distribution, sale or dispensing of any drug or mixture of drugs, and in particular, ss. 5 and 15(1) of the Ontario Drug Benefit Act, R.S.O. 1990, c. O.10, as amended;
  • Engaged in conduct or performed an act relevant to the practice of pharmacy that, having regard to all the circumstances, would reasonably be regarded by members of the profession as disgraceful, dishonourable or unprofessional.

Hearing Dates: TBA

Summary of Allegations

As a result of a referral by the Inquiries, Complaints and Reports Committee, it is alleged that Atef Besada, while engaged in the practice of pharmacy as dispensing pharmacist, Designated Manager, shareholder and/or director at Main Drug Mart on Trethewey Drive in Toronto, Ontario from about December 1, 2015 to May 28, 2019, committed professional misconduct in that he:

  • Submitted false claims for one or more of certain identified drugs and other products that were not actually dispensed to patients.

In particular, it is alleged that he:

  • Failed to maintain the standards of practice of the profession;
  • Falsified records relating to his practice;
  • Signed or issued, in his professional capacity, a document that he knew or ought to have known contained a false or misleading statement;
  • Submitted an account or charge for services or products that he knew or ought to have known was false or misleading;
  • Contravened the Pharmacy Act, the Drug and Pharmacies Regulation Act, the Regulated Health Professions Act, 1991, or the regulations under those Acts, and in particular, ss. 155 and 156 of the Drug and Pharmacies Regulation Act, R.S.O. 1990, c. H-4, as amended;
  • Contravened a federal or provincial law or municipal by-law with respect to the distribution, sale or dispensing of any drug or mixture of drugs, and in particular, ss. 5 and 15(1) of the Ontario Drug Benefit Act, R.S.O. 1990, c. O.10, as amended;
  • Engaged in conduct or performed an act relevant to the practice of pharmacy that, having regard to all the circumstances, would reasonably be regarded by members of the profession as disgraceful, dishonourable or unprofessional.

Hearing Dates: TBA

Summary of Allegations

As a result of a referral by the Inquiries, Complaints and Reports Committee, it is alleged that Atef Besada, while engaged in the practice of pharmacy as dispensing pharmacist, Designated Manager, shareholder and/or director at Main Drug Mart in Toronto, Ontario from about October 1, 2015 to May 28, 2019, and/or as shareholder and/or director at Central Weston Pharmacy in Toronto, Ontario, from about March 1, 2016 to July 23, 2019, committed professional misconduct in that he:

  • Submitted false claims for one or more of certain identified drugs and other products that were not actually dispensed to patients.

In particular, it is alleged that he:

  • Failed to maintain the standards of practice of the profession;
  • Falsified records relating to his practice;
  • Signed or issued, in his professional capacity, a document that he knew or ought to have known contained a false or misleading statement;
  • Submitted an account or charge for services or products that he knew or ought to have known was false or misleading;
  • Contravened the Pharmacy Act, the Drug and Pharmacies Regulation Act, the Regulated Health Professions Act, 1991, or the regulations under those Acts, and in particular, ss. 155 and 156 of the Drug and Pharmacies Regulation Act, R.S.O. 1990, c. H-4, as amended;
  • Contravened a federal or provincial law or municipal by-law with respect to the distribution, sale or dispensing of any drug or mixture of drugs, and in particular, ss. 5 and 15(1) of the Ontario Drug Benefit Act, R.S.O. 1990, c. O.10, as amended;
  • Engaged in conduct or performed an act relevant to the practice of pharmacy that, having regard to all the circumstances, would reasonably be regarded by members of the profession as disgraceful, dishonourable or unprofessional.

Hearing Dates: TBA

Summary of Allegations

As a result of a referral by the Inquiries, Complaints and Reports Committee, it is alleged that Mr. Billings committed professional misconduct in that

  • on July 18, 2016 in the Ontario Court of Justice at Lindsay, Ontario, he was found guilty of one count of use of a forged document, contrary to Section 368(1)(a) of the Criminal Code of Canada; and one count of fraud not exceeding $5,000.00, contrary to Section 380(1)(b) of the Criminal Code of Canada;
  • beginning in January 2012 and continuing to February 1, 2016 he self-prescribed medication, by filling out prescriptions for himself and signing the name of his previous family doctor on theprescriptions.

In particular, it is alleged that he

  • was found guilty of offenses that are relevant to his suitability to practice;
  • dispensed or sold drugs for an improper purpose;
  • falsified a record relating to his practice;
  • engaged in conduct or performed an act relevant to the practice of pharmacy that, having regard to all the circumstances, would reasonably be regarded by members as disgraceful, dishonourable or unprofessional.

Hearing Dates: TBA

Summary of Allegations

As a result of a referral by the Inquiries, Complaints and Reports Committee, it is alleged that Michael El Rabeb, while engaged in the practice of pharmacy as owner, director, shareholder, and/or dispensing pharmacist at Westboro Pharmasave in Ottawa, Ontario, committed professional misconduct in that he:

  • Submitted (or permitted, consented to, or approved, expressly or by implication, the submissions of) claims with excessive markups for one or more of certain identified drugs and/or products from in or about November 1, 2016 to in or about April 30, 2018;
  • Submitted (or permitted, consented to, or approved, expressly or by implication, the submissions of) claims to multiple plans where one or more of those plans was not obligated to pay the claim (or the full amount of the claim) for one or more of certain identified drugs and/or products from in or about November 1, 2016 to in or about April 30, 2018; and/or
  • Submitted (or permitted, consented to or approved, expressly or by implication, the submissions of) claims for dispensing fees for compliance packages at more frequent intervals than the compliance packages were being dispensed for one or more patients from in or about May 1, 2018 to in or about April 24, 2019.

In particular, it is alleged that he:

  • Failed to maintain a standard of practice of the profession;
  • Failed to keep records as required respecting his patients and/or practice;
  • Falsified a record relating to his practice and/or a person’s health record;
  • Signed and/or issued, in his professional capacity, a document that he knew and/or ought to have known contained a false and/or misleading statement;
  • Submitted an account and/or charge for services and/or products that he knew and/or ought to have known was false and/or misleading;
  • Charged a fee and/or amount that was excessive in relation to the service and/or product provided;
  • Engaged in conduct or performed an act relevant to the practice of pharmacy that, having regard to all the circumstances, would reasonably be regarded by members as disgraceful, dishonourable and/or unprofessional.

Hearing Dates: TBA

Summary of Allegations

As a result of a referral by the Inquiries, Complaints and Reports Committee, it is alleged that Michael El Raheb, in response to an investigation by the Ontario College of Pharmacists (the “College”) into his conduct at Westboro Pharmasave in Ottawa, Ontario, committed professional misconduct in that he:

  • Provided falsified employment records and/or other pharmacy records to the College;
  • Provided false and/or misleading information to the College in written submissions, emails, and/or other correspondence; and/or
  • Refused to provide relevant documents to College investigators upon request.

In particular, it is alleged that he:

  • Contravened the Regulated Health Professions Act, 1991, as amended, and in particular:
    • Subsections 76(3) and 76(3.1) of the Health Professions Procedural Code to the Regulated Health Professions Act, 1991;
  • Engaged in conduct or performed an act relevant to the practice of pharmacy that, having regard to all the circumstances, would reasonably be regarded by members as disgraceful, dishonourable and/or unprofessional.

Hearing Dates: TBA

Summary of Allegations

As a result of a referral by the Inquiries, Complaints and Reports Committee, it is alleged that Shereen El-Azrak committed professional misconduct in that

  • On September 25, 2018, in the Superior Court of Justice at Newmarket, she was found guilty of trafficking in fentanyl and possession of fentanyl for the purpose of trafficking, contrary to s. 5 of the Controlled Drugs and Substances Act, S.C. 1996, c. 19.

In particular, it is alleged that she

  • Was found guilty of offences that are relevant to her suitability to practice.

 

Hearing Dates: TBA

Summary of Allegations

As a result of a referral by the Inquiries, Complaints and Reports Committee, it is alleged that John Gerges, while engaged in the practice of pharmacy as director, shareholder, owner, Designated Manager, and/or dispensing pharmacist at Totten Pharmacy in Windsor, Ontario, and/or director, shareholder, owner, Designated Manager, and/or dispensing pharmacist at Jimmy’s Pharmacy in Toronto, Ontario, and/or director, shareholder, owner, Designated Manager, and/or dispensing pharmacist at Pacific Pharmacy in Toronto, Ontario committed professional misconduct in that he:

  • Submitted (or permitted, consented to or approved, expressly or by implication, the submissions of) charges for drugs and/or products that were never dispensed for one or more of certain identified drugs and/or products;
  • Falsified (or permitted, consented to or approved, expressly or by implication, the falsification of) pharmacy records regarding one or more of certain identified drugs and/or products;
  • Forged (or permitted, consented to or approved, expressly or by implication, the forgery of) prescriptions using a stolen prescription pad to support charges for one or more of certain identified drugs/and or products;
  • Failed to keep records as required regarding one or more of certain identified drugs and/or products; and/or
  • Submitted (or permitted, consented to or approved, expressly or by implication, the submissions of) charges for approximately 755 claims for drugs, products, and/or fees in excess of the allowable amounts and/or markups permitted by [Claims Adjudicator].

In particular, it is alleged that he:

  • Failed to maintain a standard of practice of the profession;
  • Failed to keep records as required respecting his patients and/or practice;
  • Falsified a record relating to his practice and/or a person’s health record;
  • Signed or issued, in his professional capacity, a document that he knew and/or ought to have known contained a false or misleading statement;
  • Submitted an account or charge for services and/or products that he knew and/or ought to have known was false or misleading;
  • Charged a fee and/or amount that was excessive in relation to the service and/or product provided;
  • Engaged in conduct or performed an act relevant to the practice of pharmacy that, having regard to all the circumstances, would reasonably be regarded by members as disgraceful, dishonourable or unprofessional.

Hearing Dates: TBA

Summary of Allegations

As a result of a referral by the Inquiries, Complaints and Reports Committee, it is alleged that Mr. Girgis Boktor, as pharmacist at Ancaster Village Pharmacy in Ancaster, Ontario, and/or as director of the corporation that owns and operates the Pharmacy, committed professional misconduct in that he

  • Submitted claims to [Claims Adjudicator] that included markups on the unit drug cost that were excessive and unreasonable, in or about February 2017-February 2018.

In particular, it is alleged that he

  • Failed to maintain a standard of practice of the profession
  • Charged a fee that was excessive in relation to the service provided
  • Charged a fee or amount that was excessive in relation to the service or product provided
  • Engaged in conduct or performed an act relevant to the practice of pharmacy that, having regard to all the circumstances, would reasonably be regarded by members as disgraceful, dishonourable or unprofessional

Hearing Dates: TBA

Summary of Allegations

As a result of a referral by the Inquiries, Complaints and Reports Committee, it is alleged that Mr. Guerguis, as a pharmacist and/or Designated Manager at Martindale IDA Pharmacy in St. Catharines, Ontario, committed professional misconduct in that he

  • Submitted claims to [Insurance Claims Adjudicator] that included markups on the unit drug cost that were excessive and unreasonable, in or about March 2017-March 2018

In particular, it is alleged that he

  • Failed to maintain a standard of practice of the profession
  • Charged a fee that was excessive in relation to the service provided
  • Charged a fee or amount that was excessive in relation to the service or product provided
  • Engaged in conduct or performed an act relevant to the practice of pharmacy that, having regard to all the circumstances, would reasonably be regarded by members as disgraceful, dishonourable or unprofessional

Hearing Dates: TBA

Summary of Allegations

As a result of a referral by the Inquiries, Complaints and Reports Committee, it is alleged that Mr. Hanna, while engaged in the practice of pharmacy as owner, Designated Manager, or dispensing pharmacist at the Cotton Mill Pharmacy in Cornwall, committed professional misconduct in that he

  • Charged an excessive fee to patient [Name] in relation to her prescription for Nabilone 0.5mg/ml

In particular, it is alleged that he

  • Failed to maintain a standard of practice of the profession
  • Charged a fee or amount that was excessive in relation to the service or product provided
  • Engaged in conduct or performed an act relevant to the practice of pharmacy that, having regard to all the circumstances, would reasonably be regarded by members of the profession as disgraceful, dishonourable or unprofessional

Hearing Dates: TBA

Summary of Allegations

As a result of a referral by the Inquiries, Complaints and Reports Committee, it is alleged that Mr. Hanna, while engaged in the practice of pharmacy as owner, Designated Manager, or dispensing pharmacist at the Cotton Mill Pharmacy in Cornwall, committed professional misconduct in that he

  • Charged an excessive fee in relation to the prescription of patient [Name] for Ziprasidone 15mg;
  • Failed to inform the parents of patient [Name] of less expensive ways in which the same medication could be prepared

In particular, it is alleged that he

  • Failed to maintain a standard of practice of the profession
  • Charged a fee or amount that was excessive in relation to the service or product provided
  • Engaged in conduct or performed an act relevant to the practice of pharmacy that, having regard to all the circumstances, would reasonably be regarded by members of the profession as disgraceful, dishonourable or unprofessional

Hearing Dates: TBA

Summary of Allegations

As a result of a referral by the Inquiries, Complaints and Reports Committee, it is alleged that Yasser Ibrahim, while engaged in the practice of pharmacy as director, shareholder, owner, Designated Manager, and/or dispensing pharmacist at Shoppers Drug Mart Pharmacy at 900 Maple Avenue in Burlington, Ontario and/or at Shoppers Drug Mart Pharmacy at 503 Plains Road East in Burlington, Ontario (collectively, the “Pharmacies”), committed professional misconduct in that he:

  • Submitted (or permitted, consented to or approved, expressly or by implication, the submissions of) charges for drugs and/or products that were never dispensed and/or that were not authorized for one or more of certain identified drugs and/or products between in or about January 2012 and in or about May 2019;
  • Provided pharmaceutical care to himself and/or one or more family members on one or more occasions between in or about May 2017 and in or about May 2019;
  • Submitted false claims, falsified records, and/or failed to keep records as required with respect to approximately 2 claims for MedsCheck reviews in or about October 2018; and/or
  • Transferred, sold, and/or provided narcotics and/or controlled drugs to another pharmacy in circumstances prohibited by the Narcotic Control Regulations, CRC c 1041 with respect to one or more of certain identified prescriptions between in or about October 2013 and in or about January 2019.

In particular, it is alleged that he:

  • Failed to maintain a standard of practice of the profession;
  • Failed to keep records as required respecting his patients and/or practice;
  • Falsified a record relating to his practice and/or a person’s health record;
  • Signed or issued, in his professional capacity, a document that he knew and/or ought to have known contained a false or misleading statement;
  • Submitted an account or charge for services or products that he knew and/or ought to have known was false or misleading;
  • Contravened a federal, provincial or territorial law with respect to the distribution, sale or dispensing of any drug or mixture of drugs, with respect to the distribution, purchase, sale, dispensing or prescribing of any drug or product, the administering of any substance, or the piercing of the dermis, whose purpose is to protect or promote the public health, and/or that is otherwise relevant to his suitability to practise, and in particular:
    • Sections 31 and/or 45 of the Narcotic Control Regulations, CRC c 1041, as amended;
  • Engaged in conduct or performed an act relevant to the practice of pharmacy that, having regard to all the circumstances, would reasonably be regarded by members as disgraceful, dishonourable and/or unprofessional.

Hearing Dates: TBA

Summary of Allegations

As a result of a referral by the Inquiries, Complaints and Reports Committee, it is alleged that Ms. Iskandar, while engaged in the practice of pharmacy as Designated Manager and/or dispensing pharmacist at Clinic Pharmacy in Midland, and/or as a director and/or shareholder of the corporation that owned and/or operated the Pharmacy, committed professional misconduct in that:

    • Between about January 9, 2013 and March 28, 2017, she failed to actively and effectively participate in and/or monitor the day-to-day management of the Pharmacy, including, but not limited to drug procurement and inventory management, record keeping and documentation, billing, and staff and personnel management, and/or she failed to actively and effectively fulfill the duties and responsibilities of a Designated Manager;
    • Between about January 9, 2013 and March 28, 2017, she operated (or permitted, consented to or approved, expressly or impliedly, the operation of) the Pharmacy when it was not managed by a pharmacist who was designated as the Designated Manager of the Pharmacy;
    • Between about June 16, 2016 and March 28, 2017, she failed to ensure that her name, certificate of registration, or both were clearly and publicly displayed in the Pharmacy;
    • On or about January 9, 2013, she signed an Acknowledgment/Change of Designated Manager form containing a false or misleading statement by indicating that “[A.N.]” did not continue to work at the Pharmacy;
    • Between about December 2014 and December 2016, she created (or permitted, consented to or approved, expressly or impliedly, the creation of) false and/or misleading pharmacy records documenting the dispensing of brand name medication when generic medication was dispensed, with respect to certain identified medication;
    • Between about December 2014 and December 2016, she submitted (or permitted, consented to or approved, expressly or impliedly, the submission of) charges for brand name medication when generic medication was dispensed, with respect to certain identified medication;
    • Between about December 2014 and December 2016, she created (or permitted, consented to or approved, expressly or impliedly, the creation of) false and/or misleading pharmacy records documenting the dispensing of drugs and/or products that were not dispensed, with respect to certain identified drugs and/or products;
    • Between about December 2014 and December 2016, she submitted (or permitted, consented to or approved, expressly or impliedly, the submission of) charges for drugs and/or products that were not dispensed, with respect to certain identified drugs and/or products;
    • Between about June 2015 and December 2016, she permitted, consented to or approved, expressly or impliedly, the provision of routine pharmaceutical care to family members including herself and/or one or more of [family members] by [person] as dispensing pharmacist;
    • Between about June 2015 and December 2016, she permitted, consented to or approved, expressly or impliedly, the selling of certain identified prescription drugs and/or products without valid prescriptions;
    • Between about June 2015 and December 2016, she created (or permitted, consented to or approved, expressly or impliedly, the creation of) false and/or misleading pharmacy records documenting the selling of certain identified prescription drugs and/or products and/or the processing of prescriptions when those prescriptions were not valid;
    • Between about June 2015 and December 2016, she submitted (or permitted, consented to or approved, expressly or impliedly, the submission of) charges for certain identified prescription drugs and/or products without valid prescriptions.

In particular, it is alleged that she

  • Failed to maintain a standard of practice of the profession;
  • Falsified a record relating to her practice;
  • Signed or issued in her professional capacity a document that she knew contained a false or misleading statement;
  • Submitted an account or charge for services that she knew was false or misleading
  • Contravened the Pharmacy Act, 1991, the Drug and Pharmacies Regulation Act, the Regulated Health Professions Act, 1991 or the regulations under those Acts, and in particular:
    • s. 146(1) of the Drug and Pharmacies Regulation Act, R.S.O. 1990, c. H.4;
    • s. 146(3) of the Drug and Pharmacies Regulation Act, R.S.O. 1990, c. H.4;
    • s. 155 of the Drug and Pharmacies Regulation Act, R.S.O. 1990, c. H.4;
  • Contravened a federal or provincial law or municipal by-law with respect to the distribution, sale or dispensing of any drug or mixture of drugs, and in particular:
    • s. 15(1)(b) of the Ontario Drug Benefit Act, R.S.O. 1990, c. O.10;
    • s. 15(1)(b) of the Ontario Drug Benefit Act, R.S.O. 1990, c. O.10;
    • s. C.01.041 of the Food and Drug Regulations, C.R.C. 870, made under the Food and Drugs Act, R.S.C. 1985, c. F-27;
  • Permitted, consented to or approved, either expressly or by implication, the commission of an offence against an Act relating to the practice of pharmacy or to the sale of drugs by a corporation of which she was a director;
  • Engaged in conduct or performed an act relevant to the practice of pharmacy that, having regard to all the circumstances, would reasonably be regarded by members of the profession as disgraceful, dishonourable or unprofessional.

Hearing Dates: TBA

Summary of Allegations

As a result of a referral by the Inquiries, Complaints and Reports Committee, it is alleged that John Kaldus, while practicing pharmacy as Designated Manager, director and shareholder, and/or dispensing pharmacist at Elliot Lake Health Centre Pharmachoice in Elliot Lake, Ontario and/or Robinson’s Pharmasave in Espanola, Ontario, in the period from about August 2014 to February 2018, committed professional misconduct in that he:

  • Failed to keep records as required by the College’s Medication Procurement and Inventory Management Policy with respect to the inventory of narcotics and controlled drugs;
  • Directed non-pharmacist employees to dispense methadone to patients;
  • Misappropriated prescription drugs and/or controlled substances from the pharmacy, including:
    • Oxycocet;
    • Tylenol #3 and/or Ratio-Lenoltec #3;
    • Clonazepam; and/or
    • Tramadol.

In particular, it is alleged that he:

  • Failed to maintain a standard of practice of the profession;
  • Failed to keep records as required;
  • Contravened s. 149(1) of the Drug and Pharmacies Regulation Act, R.S.O. 1990, c. H.4;
  • Contravened a federal or provincial law or municipal by-law with respect to the distribution, sale or dispensing of any drug or mixture of drugs, specifically
    • s. 4 of the Controlled Drugs and Substances Act;
    • s. 51(1) of the Benzodiazepines and Other Targeted Substances Regulations, SOR/2000-217;
    • s. 31(1) of the Narcotic Control Regulations, C.R.C., c. 1041
  • Engaged in conduct or performed an act relevant to the practice of pharmacy that, having regard to all the circumstances, would reasonably be regarded by members of the profession as disgraceful, dishonourable or unprofessional.

Hearing Dates: TBA

Summary of Allegations

As a result of a referral by the Inquiries, Complaints and Reports Committee, it is alleged that John Kaldus, while practicing pharmacy as Designated Manager, director and shareholder, and/or dispensing pharmacist at Elliot Lake Health Centre Pharmachoice in Elliot Lake, Ontario and/or Robinson’s Pharmasave in Espanola, Ontario, in the period from about December 2015 to April 2019, committed professional misconduct in that he:

  • Failed to report to the Registrar that he had been charged criminally with offences under the Controlled Drugs and Substances Act on or about December 24, 2015;
  • Unlawfully possessed the following controlled substances without a prescription when stopped by police in King Township, Ontario on December 24, 2015:
    • Oxycontin;
    • Oxycocet;
    • Oxycodone; and/or
    • Morphine.

In particular, it is alleged that he:

  • Contravened a term, condition or limitation imposed on his certificate of registration;
  • Failed to maintain a standard of practice of the profession;
  • Contravened a federal or provincial law or municipal by-law with respect to the distribution, sale or dispensing of any drug or mixture of drugs, specifically:
    • s. 4 of the Controlled Drugs and Substances Act, S.C. 1996, c. 19;
  • Engaged in conduct or performed an act relevant to the practice of pharmacy that, having regard to all the circumstances, would reasonably be regarded by members of the profession as disgraceful, dishonourable or unprofessional.

Hearing Dates: TBA

Summary of Allegations

As a result of a referral by the Inquiries, Complaints and Reports Committee, it is alleged that Shamez Kassam, while engaged in the practice of pharmacy as dispensing pharmacist and/or a director and/or shareholder of the corporation that owned and/or operated Chapmans Pharmacy in London, Ontario (the “Pharmacy”), committed professional misconduct with respect to the following:

  • At various times between about February 2010 and June 12, 2019, he submitted (or permitted, consented to or approved, expressly or impliedly, the submission of) charges for drugs and/or products that were not dispensed, including:
    1. by instructing staff (or permitting, consenting to or approving, expressly or impliedly, the instruction to staff) to not cancel prescriptions that had been billed but not dispensed to patients, and/or
    2. with respect to certain identified drugs and/or;
  • Between about October 1, 2017 and November 30, 2017, he cancelled (or permitted, consented to or approved, expressly or impliedly, the cancellation of) prescriptions for which the Pharmacy was not entitled to payment, without taking the steps (or ensuring the steps were taken) that were necessary to ensure the reversal of the charges billed by the Pharmacy, with respect to certain identified prescriptions;
  • Between about September 1, 2015 and October 1, 2017, he submitted (or permitted, consented to or approved, expressly or impliedly, the submission of) certain identified claims to the Ontario Drug Benefit Program for which he was required to have and maintain records that he did not have and/or maintain;
  • Between about September 1, 2015 and October 1, 2017, he submitted (or permitted, consented to or approved, expressly or impliedly, the submission of) certain identified claims to the Ontario Drug Benefit Program and accepted payment for those claims without being entitled to payment;
  • At various times between about February 2010 and June 12, 2019, he instructed staff to dispense methadone and/or Suboxone to patients without a pharmacist present to witness the patient’s dose, and/or he participated in, permitted, consented to, or approved, either expressly or impliedly, that practice;
  • At various times between about February 2010 and June 12, 2019, he instructed staff to dispense prescription medication to patients without ensuring that a pharmacist or registered pharmacy technician had verified the prescription and its preparation, and had signed the prescription hardcopy, and/or he participated in, permitted, consented to, or approved, either expressly or impliedly, that practice;
  • At various times between about February 2010 and June 12, 2019, he instructed staff to sign prescription hardcopies in a manner intended to or that he ought reasonably to have expected would be confused for a pharmacist’s signature, and/or he participated in, permitted, consented to, or approved, either expressly or impliedly, that practice;
  • At various times between about May 27, 2014 and June 12, 2019, he failed to ensure appropriate staffing levels in the Pharmacy to enable himself and other staff to maintain the accepted standard of pharmacy practice and to deliver safe and effective patient care;
  • Between about December 2016 and February 2017, he instructed staff to dispense reconstituted powdered methadone to patients while billing those patients’ prescriptions as though Methadose had been dispensed, and/or he participated in, permitted, consented to, or approved, either expressly or impliedly, that practice;
  • Between about January 1, 2016 and December 31, 2018, he failed to report (or ensure the reporting of) a loss or theft of narcotics relating to losses of Hydromorph contin 18mg, 24mg, and/or 30mg, as required by s. 42 of the Narcotic Control Regulations, CRC, c. 1041;
  • Between about January 1, 2016 and June 12, 2019, he failed to ensure that inventory reconciliations of narcotics and controlled/targeted substances were performed at least every six months and/or with reasonable/required frequency.

In particular, it is alleged that he:

  • Failed to maintain a standard of practice of the profession;
  • Failed to keep records as required respecting his patients or practice;
  • Falsified a record relating to his practice and/or to a person’s health record;
  • Submitted an account or charge for services or products that he knew or ought to know was false or misleading;
  • Contravened the Pharmacy Act, the Drug and Pharmacies Regulation Act, the Regulated Health Professions Act, 1991, or the regulations under those Acts, and in particular:
    • s. 156(1)(g) of the Drug and Pharmacies Regulation Act, RSO 1990, c H.4;
  • Contravened a federal or provincial or territorial law or municipal by-law with respect to the distribution, purchase, sale, or dispensing or prescribing of any drug or mixture of drugs or product, and in particular:
    • ss. 5, 6, and/or 15(1)(b) of the Ontario Drug Benefits Act, RSO 1990, c O.10, as amended;
    • s. 42 of the Narcotic Control Regulations, CRC, c. 1041;
  • Engaged in conduct or performed an act relevant to the practice of pharmacy that, having regard to all the circumstances, would reasonably be regarded by members of the profession as disgraceful, dishonourable or unprofessional.

Hearing Dates: TBA

Summary of Allegations

As a result of a referral by the Inquiries, Complaints and Reports Committee, it is alleged that Ms. Khan, while engaged in the practice of pharmacy as a dispensing pharmacist at Shoppers Drug Mart, located at 300 Taunton Road East in Oshawa (“SDM Taunton”) and/or at Shoppers Drug Mart located at 20 Warren Road in Oshawa (“SDM Warren”), committed professional misconduct in that she

  • Was found guilty of an offence that is relevant to her suitability to practise with respect to findings of guilt made on December 18, 2017, by the Ontario Court of Justice at Oshawa in relation to the following counts:
    • Theft of Oxycocet exceeding $5,000, contrary to section 334(a) of the Criminal Code of Canada;
    • Fraud with respect to Oxycocet exceeding $5,000, contrary to section 380(1)(a) of the Criminal Code of Canada;
    • Theft of Oxycocet not exceeding $5,000, contrary to section 334(b) of the Criminal Code of Canada; and/or
    • Fraud with respect to Oxycocet not exceeding $5,000, contrary to section 380(1)(b) of the Criminal Code of Canada;
  • In the period from in or about February 17, 2017, to April 29, 2017, she misappropriated at least 11,830 tablets of Ratio-Oxycocet and/or Sandoz-Oxycodone Acetaminophen, without authorization or record, from SDM Taunton;
  • In the period from in or about April 5, 2016, to December 10, 2016, she misappropriated at least 78,045 tablets of Ratio-Oxycocet, without authorization or record, from SDM Warren;
  • In the period from in or about February 17, 2017, to April 29, 2017, she submitted approximately 28 false claims, for which there were no valid prescriptions and for which payment was not required, to the Ontario Drug Benefit program (“ODB”) from SDM Taunton; and/or
  • In the period from in or about April 5, 2016, to December 10, 2016, she submitted approximately 304 false claims, for which there were no valid prescriptions and for which payment was not required, to the ODB from SDM Warren.

In particular, it is alleged that she

  • Was found guilty of an offence that is relevant to her suitability to practice;
  • Failed to maintain a standard of practice of the profession;
  • Dispensed or sold drugs for an improper purpose;
  • Failed to keep records as required respecting her patients;
  • Falsified a record relating to her practice;
  • Signed or issued, in her professional capacity, a document that she knew contained a false or misleading statement;
  • Submitted an account or charge for services that she knew was false or misleading
  • Contravened the Act, the Drug and Pharmacies Regulation Act, the Regulated Health Professions Act, 1991 or the regulations under those Acts, and in particular:
    • Section 155 of the Drug and Pharmacies Regulation Act
  • Contravened a federal or provincial law or municipal by-law with respect to the distribution, sale or dispensing of any drug or mixture of drugs, and in particular:
    • Sections C.01.041, G.03.002, and/or G.03.012 of the Food and Drug; Regulations, C.R.C., c. 870, as amended, to the Food and Drugs Act, R.S,C. 1985, c. F-27, as amended;
    • Section 4 of the Controlled Drugs and Substances Act, S.C. 1996, c. 19, as amended;
    • Section 31 of the Narcotic Control Regulations, C.R.C., c. 1041, as amended, to the Controlled Drugs and Substances Act, S.C. 1996, c. 19, as amended;
    • Section 8 of the Narcotics Safety and Awareness Act, 2010, S.O. 2010, c.22, as amended, and the Notice issued thereunder, and/or section 11 of the Narcotic Safety and Awareness Act, 2010, S.O. 2010 C.22, as amended;
    • Section 15 of the Ontario Drug Benefit Act, R.S.O. 1990, C.0.10, as amended;
    • Sections 334(a), 334(b), 380(1)(a), and/or 380(1)(b) of the Criminal Code of Canada;
  • Knowingly permitted the premises in which a pharmacy was located to be used for unlawful purposes;
  • Engaged in conduct or performed an act relevant to the practice of pharmacy that, having regard to all the circumstances, would reasonably be regarded by members of the profession as disgraceful, dishonourable or unprofessional.

 

Hearing Dates: TBA

Summary of Allegations

As a result of a referral by the Inquiries, Complaints and Reports Committee, it is alleged that Nimet Lalji, from in or about May 2015 to in or about April 2017, while engaged in the practice of pharmacy as director, shareholder, owner, Designated Manager, and/or dispensing pharmacist at Express Aid I.D.A. Pharmacy (the “Pharmacy”) in Barrie, Ontario, committed professional misconduct in that she

  • Submitted false, misleading, inaccurate, and/or unsubstantiated claims to the Ontario Drug Benefit Program for one or more of certain identified drugs and/or products and/or one or more of certain identified claims; and/or
  • Failed to keep records as required with respect to one or more of certain identified drugs and/or products and/or one or more of certain identified claims submitted to the Ontario Drug Benefit Program;
  • Dispensed and/or billed for drugs and/or products without a prescription authorized by a prescriber for one or more of certain identified drugs and/or products.

In particular, it is alleged that she

  • Failed to maintain a standard of practice of the profession;
  • Failed to keep records as required respecting her patients;
  • Falsified a record relating to her practice;
  • Signed or issued, in her professional capacity, a document that she knew or ought to have known contained a false or misleading statement;
  • Submitted an account or charge for services or products that she knew or ought to have known was false or misleading;
  • Contravened the Pharmacy Act, 1991, the Drug and Pharmacies Regulation Act, the Regulated Health Professions Act, 1991, or the regulations under those Acts, and in particular:
    • sections 155, 156, and 166 of the Drug and Pharmacies Regulation Act, as amended;
    • section 20(1) of Ontario Regulation 264/16, as amended; and
    • section 54(1) of Ontario Regulation 58/11, as amended;
  • Contravened a federal or provincial law or municipal by-law with respect to the distribution, sale or dispensing of any drug or mixture of drugs, and in particular:
    • sections 155, 156, and 166 of the Drug and Pharmacies Regulation Act, as amended;
    • section 20(1) of Ontario Regulation 264/16, as amended;
    • section 54(1) of Ontario Regulation 58/11, as amended;
    • sections 5, 6, 15(1), 17(2), and/or 23(1) of the Ontario Drug Benefit Act, as amended; and/or
    • sections 18, 19, 27, and/or 29(1) of Ontario Regulation 201/96, as amended;
  • Engaged in conduct or performed an act relevant to the practice of pharmacy that, having regard to all the circumstances, would reasonably be regarded by members as disgraceful, dishonourable or unprofessional.

 

 

 

Hearing Dates: TBA

Summary of Allegations

As a result of a referral by the Inquiries, Complaints and Reports Committee, it is alleged that Nimet Lalji, while engaged in the practice of pharmacy as director, shareholder, owner, Designated Manager, and/or dispensing pharmacist at Express Aid Pharmacy located on Grove Street in Barrie, Ontario, Express Aid Pharmacy located on Leacock Drive in Barrie, Ontario, and/or Express Aid IDA Pharmacy located on Hurst Drive in Barrie, Ontario, committed professional misconduct in that she:

  • Submitted (or permitted, consented to or approved, expressly or by implication, the submissions of) charges for drugs and/or products that were never dispensed and/or that were not authorized for one or more of certain identified prescriptions;
  • Failed to keep records as required respecting her patients and/or practice with respect to one or more of certain identified prescriptions;
  • Altered and/or falsified records respecting her patients and/or practice with respect to one or more of certain identified prescriptions; and/or
  • Renewed patient prescriptions in a manner that contravened the requirements of O. Reg 202/94 to the Pharmacy Act, 1991, as amended, with respect to one or more of certain identified prescriptions.

In particular, it is alleged that she:

  • Failed to maintain a standard of practice of the profession;
  • Failed to keep records as required respecting her patients and/or practice;
  • Falsified a record relating to her practice and/or a person’s health record;
  • Signed or issued, in her professional capacity, a document that she knew and/or ought to have known contained a false or misleading statement;
  • Submitted an account or charge for services or products that she knew and/or ought to have known was false or misleading;
  • Contravened the Pharmacy Act, 1991, the Drug and Pharmacies Regulation Act, the Regulated Health Professions Act, 1991, and/or the regulations under those Acts, and, in particular:
    • section 4 of the Pharmacy Act, 1991, as amended, and/or
    • sections 36, 37, and/or 38 of O Reg 202/94 to the Pharmacy Act, 1991, as amended;
  • Engaged in conduct or performed an act relevant to the practice of pharmacy that, having regard to all the circumstances, would reasonably be regarded by members as disgraceful, dishonourable and/or unprofessional.

Hearing Dates: TBA

Summary of Allegations

As a result of a referral by the Inquiries, Complaints and Reports Committee, it is alleged that Mr. Ma, while engaged in the practice of pharmacy as director, shareholder, owner, Designated Manager, and/or dispensing pharmacist at Pharm Can Drug Mart (the “Pharmacy”) in Ottawa, committed professional misconduct in that he:

  • Dispensed monitored drugs without acting on Narcotic Monitoring System alerts for one or more of certain identified prescriptions;
  • Dispensed monitored drugs without documenting the actions taken, and/or the reason(s) for not taking any action, in response to Narcotic Monitoring System alerts for one or more of certain identified prescriptions; and/or,
  • Dispensed one or more of certain identified prescriptions without labelling the container in which the drug(s) was dispensed.

In particular, it is alleged that he:

  • Failed to maintain a standard of practice of the profession;
  • Failed to keep records as required respecting his patients and/or practice;
  • Contravened the Act, the Drug and Pharmacies Regulation Act, the Regulated Health Professions Act, 1991, or the regulations under those Acts, and in particular:
    • Sections 156 and 166 of the Drug and Pharmacies Regulation Act, section 20(1) of Ontario Regulation 264/16, and/or
    • Section 54 of Ontario Regulation 58/11;
  • Engaged in conduct or performed an act relevant to the practice of pharmacy that, having regard to all the circumstances, would reasonably be regarded by members as disgraceful, dishonourable or unprofessional

 

Hearing Dates: TBA

Summary of Allegations

As a result of a referral by the Inquiries, Complaints and Reports Committee, it is alleged that Guo Ma, from in or about March 2015 to in or about November 2017, while engaged in the practice of pharmacy as director, shareholder, owner, designated manager, and/or dispensing pharmacist at Pharm Can Drug Mart (the “Pharmacy”) in Ottawa, Ontario, committed professional misconduct in that he

  • Dispensed and/or billed for drugs and/or products without a prescription authorized by a prescriber for one or more of certain identified drugs and/or products;
  • Submitted an account or charge for services that he knew was false or misleading with respect to:
    1. one or more of certain identified drugs and/or products; and/or,
    2. one or more of certain identified claims to the Ontario Drug Benefit Program; and/or,
  • Falsified a record relating to his practice with respect to:
    1. one or more of certain identified drugs and/or products; and/or,
    2. one or more of certain identified claims to the Ontario Drug Benefit Program; and/or,
  • Signed or issued, in his professional capacity, a document he knew contained a false and misleading statement with respect to:
    1. one or more of certain identified drugs and/or products; and/or,
    2. one or more of certain identified claims to the Ontario Drug Benefit Program; and/or,
  • Failed to keep records as required respecting his patients with respect to:
    1. one or more of certain identified drugs and/or products; and/or,
    2. one or more of certain identified claims to the Ontario Drug Benefit Program.

In particular, it is alleged that he:

  • Failed to maintain a standard of practice of the profession;
  • Failed to keep records as required respecting his patients;
  • Falsified a record relating to his practice;
  • Signed or issued, in his professional capacity, a document that he knew contained a false or misleading statement;
  • Submitted an account or charge for services or products that he knew and/or ought to have known was false or misleading;
  • Contravened the Pharmacy Act, 1991, the Drug and Pharmacies Regulation Act, the Regulated Health Professions Act, 1991, the Narcotics Safety and Awareness Act, 2010, the Drug Interchangeability and Dispensing Fee Act or the Ontario Drug Benefit Act or the regulations under those Acts, and in particular:
    • sections 155, 156, 163, and 166 of the Drug and Pharmacies Regulation Act, as amended;
    • section 20(1) of Ontario Regulation 264/16, as amended;
    • sections 40 and 54(1) of Ontario Regulation 58/11;
    • sections 5, 6, 15(1), 17(2), and/or 23(1) of the Ontario Drug Benefit Act, as amended; and/or
    • sections 18, 19, 25, 27, and/or 29(1) of Ontario Regulation 201/96, as amended;
  • Contravened a federal, provincial or territorial law with respect to the distribution, sale or dispensing of any drug or mixture of drugs, with respect to the distribution, purchase, sale, dispensing or prescribing of any drug or product, the administering of any substance, or the piercing of the dermis, whose purpose is to protect or promote the public health, and/or that is otherwise relevant to his suitability to practise, and in particular:
    • sections 155, 156, 163, and 166 of the Drug and Pharmacies Regulation Act, as amended;
    • section 20(1) of Ontario Regulation 264/16, as amended;
    • sections 40 and 54(1) of Ontario Regulation 58/11, as amended;
    • sections 5, 6, 15(1), 17(2), and/or 23(1) of the Ontario Drug Benefit Act, as amended; and/or
    • sections 18, 19, 25, 27, and/or 29(1) of Ontario Regulation 201/96, as amended;
  • Engaged in conduct or performed an act relevant to the practice of pharmacy that, having regard to all the circumstances, would reasonably be regarded by members as disgraceful, dishonourable or unprofessional.

Hearing Dates: TBA

Summary of Allegations

As a result of a referral by the Inquiries, Complaints and Reports Committee, it is alleged that Christopher MacDonald, while engaged in the practice of pharmacy at the […] Pharmacy in […], on or about December 1, 2018, committed professional misconduct in that he

  • Engaged in sexual touching of [Name] without consent.

In particular, it is alleged that he

  • Sexually abused a patient, [Name];
  • Engaged in conduct or performed an act relevant to the practice of pharmacy that, having regard to all the circumstances, would reasonably be regarded by members of the profession as disgraceful, dishonourable or unprofessional;
  • Engaged in conduct unbecoming a pharmacist.

Hearing Dates: TBA

Summary of Allegations

As a result of a referral by the Inquiries, Complaints and Reports Committee, it is alleged that Angela MacLellan, as a pharmacy technician at Custom Care Pharmacy & Compounding Centre, and Specialty Pharma Solutions, both in Oshawa, Ontario, committed professional misconduct in that she:

  • Processed, created false records, and signed prescription hardcopies for approximately 2977 transactions for prescriptions of nerve blocks that were not dispensed from Custom Care Pharmacy & Compounding Centre, from on or about December 2015 to on or about January 22, 2018; and/or
  • Processed, created false records, and signed prescription hardcopies for approximately 7161 transactions for prescriptions of nerve blocks that were not dispensed from Specialty Pharma Solutions from on or about May 2017 to on or about January 22, 2018.

In particular, it is alleged that she:

  • Failed to maintain a standard of practice of the profession;
  • Falsified a record related to her practice and/or a person’s health record;
  • Signed or issued, in her professional capacity, a document that she knew and/or ought to have known contained a false or misleading statement;
  • Engaged in conduct or performed an act relevant to the practice of pharmacy that, having regard to all the circumstances, would reasonably be regarded by members as disgraceful, dishonourable or unprofessional.

Hearing Dates: TBA

Summary of Allegations

As a result of a referral by the Inquiries, Complaints and Reports Committee, it is alleged that Shaukatali Mangalji, committed professional misconduct in that he

  • Failed to adequately supervise pharmacy assistants in the preparation of methadone and/or buprenorphine doses, and in doing so failed to comply with the National Association of Pharmacy and Regulatory Authorities Model Standards of Practice for Pharmacists;
  • Improperly delegated responsibility for supervising the administration of methadone and/or buprenorphine doses to pharmacy assistants, and in doing so failed to comply with CAMH’s Opioid Agonist Maintenance Treatment: A Pharmacist’s Guide to Methadone and Buprenorphine for Opioid Use Disorder, and/or the Ontario College of Pharmacists’ Fact Sheet: Key Requirements for Methadone Dispensing as required by the Ontario College of Pharmacists’ Opioid Policy;
  • Failed to adequately supervise pharmacy assistants [Person A] and/or [Person B] and/or [Person C] in the preparation of methadone doses for patients [Patient 1] and/or [Patient 2] and/or [Patient 3] and/or [Patient 4], from on or about January 3, 2019, to on or about May 30, 2019; and/or
  • Signed the patient methadone logs of patients [Patient 1] and/or [Patient 2] and/or [Patient 3] and/or [Patient 4], indicating that he had observed the administration of their methadone doses when he had not, from on or about January 3, 2019, to on or about May 30, 2019, and/or he signed a daily dose log indicating he observed the administration of a buprenorphine dose for patient [Patient 5] on or about July 25, 2019, when he had not.

In particular, it is alleged that he:

  • Failed to maintain standards of practice of the profession;
  • Failed to provide an appropriate level of supervision to persons for whom he was professionally obligated to supervise;
  • Falsified records relating to his practice or a person’s health record;
  • Signed or issued, in his professional capacity, a document that he knew or ought to have known contained a false or misleading statement;
  • Engaged in conduct or performed acts that, having regard to all the circumstances, would reasonably be regarded by members of the profession as unprofessional, dishonourable or disgraceful.

 

Hearing Dates: TBA

Summary of Allegations

As a result of a referral by the Inquiries, Complaints and Reports Committee, it is alleged that Mr. Mosallam, as pharmacist and/or Designated Manager at Pars Medical Pharmacy in Richmond Hill, committed professional misconduct in that he

  • Dispensed medications and/or supplies to himself, and/or submitted claims to [Insurer] for such medications or supplies, without the required authorization from a prescriber, and/or falsified records of such authorization, in relation to certain identified prescriptions;
  • Dispensed medications and/or supplies to himself, and/or submitted claims to [Insurer] for such medications or supplies, without the required authorization from a prescriber, and/or failed to document such authorization, in relation to certain identified prescriptions;
  • Dispensed medications and/or supplies to [Patient 1], and/or submitted claims to [Insurer] for such medications or supplies, without the required authorization from a prescriber, and/or falsified records of such authorization, in relation to certain identified prescriptions;
  • Dispensed medications and/or supplies to [Patient 1], and/or submitted claims to [Insurer] for such medications or supplies, without the required authorization from a prescriber, and/or failed to document such authorization, in relation to certain identified prescriptions;
  • Dispensed medications and/or supplies to [Patient 2], and/or submitted claims to [Insurer] for such medications or supplies, without the required authorization from a prescriber, and/or falsified records of such authorization, in relation to certain identified prescriptions;
  • Dispensed medications and/or supplies to [Patient 2], and/or submitted claims to [Insurer] for such medications or supplies, without the required authorization from a prescriber, and/or failed to document such authorization, in relation to certain identified prescriptions;
  • Obtained new prescriptions and/or prescription refills for himself for certain identified prescriptions;
  • Dispensed prescription medications to himself in relation to certain identified prescriptions; and/or
  • Submitted claims to [Insurer] for 200 diabetic test strips for himself on or about October 27, 2014, as though the prescription had been authorized by him in accordance with the regulations under the Pharmacy Act, 1991 which was not accurate, and/or then falsified a record retroactively to indicate that the claim had been authorized by a physician before being submitted.

In particular, it is alleged that he

  • Failed to maintain a standard of practice of the profession
  • Practised the profession while he was in a conflict of interest
  • Failed to keep records as required respecting his patients
  • Falsified a record relating to his practice
  • Signed or issued, in his professional capacity, a document that he knew contained a false or misleading statement
  • Submitted an account or charge for services that he knew was false or misleading
  • Engaged in conduct or performed an act relevant to the practice of pharmacy that, having regard to all the circumstances, would reasonably be regarded by members as disgraceful, dishonourable or unprofessional

Hearing Dates: TBA

Summary of Allegations

As a result of a referral by the Inquiries, Complaints and Reports Committee, it is alleged that Mr. Mosallam, as pharmacist and Designated Manager at Pars Medical Pharmacy in Richmond Hill, Ontario, and as shareholder of Ultra Care Pharmacy Inc., the owner and operator of the Pharmacy, committed professional misconduct in that he

  • Submitted false or unsubstantiated claims to the Ontario Drug Benefit Program totalling approximately $80,000.00 in relation to nine identified drug and/or other health products in or about January 2013-March 2015; and/or
  • Created false records of billing and/or dispensing transactions in relation to the false or unsubstantiated claims submitted to the Ontario Drug Benefit Program in relation to nine identified drug and/or other health products in or about January 2013-March 2015

In particular, it is alleged that he

  • Failed to maintain a standard of practice of the profession
  • Falsified a record relating to his practice
  • Signed or issued, in his professional capacity, a document that he knew contained a false or misleading statement
  • Submitted an account or charge for services that he knew was false or misleading
  • Contravened, while engaged in the practice of pharmacy, a federal or provincial law or municipal by-law with respect to the distribution, sale or dispensing of any drug or mixture of drugs, and in particular, the Ontario Drug Benefit Act, R.S.O. 1990 c.O. 10, sections 5, 6 and/or 15, as amended, and/or Ontario Regulation 201/96, section 27
  • Engaged in conduct or performed an act relevant to the practice of pharmacy that, having regard to all the circumstances, would reasonably be regarded by members as disgraceful, dishonourable or unprofessional

Hearing Dates: TBA

Summary of Allegations

As a result of a referral by the Inquiries, Complaints and Reports Committee, it is alleged that Mr. Odigie, while engaged in the practice of pharmacy as a Designated Manager and/or dispensing pharmacist at UniMed Dispensaries in Burlington, Ontario (the “Pharmacy”), and/or as a director and/or shareholder of the corporation that owned and/or operated the Pharmacy, committed professional misconduct in that

  • Between about May 29, 2017 and April 18, 2018, he dispensed (or permitted, consented to or approved, expressly or impliedly, the dispensing of) medication to patient [Patient 1] in strengths that were inappropriate having regard to the prescribed dose, without an appropriate clinical, therapeutic, or other basis, with respect to certain identified medication;
  • Between about May 29, 2017 and April 18, 2018, he charged (or permitted, consented to or approved, expressly or impliedly, the charging of) amounts to the Ontario Drug Benefit Program that were excessive in relation to the service or product provided, and in particular, he charged dispensing fees for dispensing medication to patient [Patient 1]in strengths that were inappropriate having regard to the prescribed dose, without an appropriate clinical, therapeutic, or other basis, with respect to certain identified medication;
  • Between about January 1, 2018 and July 17, 2018, he dispensed (or permitted, consented to or approved, expressly or impliedly, the dispensing of) medication to patient [Patient 2] in strengths that were inappropriate having regard to the prescribed dose, without an appropriate clinical, therapeutic, or other basis, with respect to certain identified medication;
  • Between about January 1, 2018 and July 17, 2018, he charged (or permitted, consented to or approved, expressly or impliedly, the charging of) amounts to the Ontario Drug Benefit Program that were excessive in relation to the service or product provided, and in particular, he charged dispensing fees for dispensing medication to patient [Patient 2]. in strengths that were inappropriate having regard to the prescribed dose, without an appropriate clinical, therapeutic, or other basis, with respect to certain identified medication;

In particular, it is alleged that he

  • Failed to maintain a standard of practice of the profession
  • Charged a fee or amount that was excessive in relation to the service or product provided
  • Engaged in conduct or performed an act relevant to the practice of pharmacy that, having regard to all the circumstances, would reasonably be regarded by members of the profession as disgraceful, dishonourable or unprofessional

Hearing Dates: TBA

Summary of Allegations

As a result of a referral by the Inquiries, Complaints and Reports Committee, it is alleged that Felix Odigie, while engaged in the practice of pharmacy as a Designated Manager and/or dispensing pharmacist at UniMed Dispensaries in Burlington, Ontario (the “Pharmacy”), and/or as a director and/or shareholder of the corporation that owned and/or operated the Pharmacy, committed professional misconduct in that:

  • Between about January 1, 2018 and February 12, 2019, he practised the profession while in a conflict of interest, and in particular, he practised as dispensing pharmacist and/or Designated Manager at the Pharmacy, while the Pharmacy engaged in financial transactions with an individual ([Name]), who was authorized to give instructions to the Pharmacy’s bank(s) and who was authorized to and did sign cheques on the Pharmacy’s bank account(s), and while all or substantially all the Pharmacy’s patients were referred to the Pharmacy by [Name];
  • Between about January 1, 2018 and February 12, 2019, he dispensed (or permitted, consented to or approved, expressly or impliedly, the dispensing of) medication to certain identified patients in combinations of strengths that were inappropriate having regard to the patients’ prescribed doses and the available strengths of the medications, without an appropriate clinical, therapeutic, or other reasonable basis;
  • Between about January 1, 2018 and February 12, 2019, he dispensed (or permitted, consented to or approved, expressly or impliedly, the dispensing of) medication to certain identified patients on a daily basis, without an appropriate clinical, therapeutic, or other reasonable basis for dispensing daily;
  • Between about January 1, 2018 and February 12, 2019, he charged (or permitted, consented to or approved, expressly or impliedly, the charging of) amounts to the Ontario Drug Benefit Program that were excessive in relation to the service or product provided, and in particular, he charged dispensing fees for dispensing medication to certain identified patients in combinations of strengths that were inappropriate having regard to the patients’ prescribed doses and the available strengths of the medications, without an appropriate clinical, therapeutic, or other basis;
  • Between about January 1, 2018 and February 12, 2019, he charged (or permitted, consented to or approved, expressly or impliedly, the charging of) amounts to the Ontario Drug Benefit Program that were excessive in relation to the service or product provided, and in particular, he charged dispensing fees for dispensing medication to certain identified patients on a daily basis, without an appropriate clinical, therapeutic, or other reasonable basis for dispensing daily;
  • Between May 7, 2018 and May 11, 2020, he provided (or permitted, consented to or approved, expressly or impliedly, the provision of) false or misleading information to an Ontario College of Pharmacists investigator in the course of their investigation into his conduct, and/or he failed to cooperate with the investigator’s investigation into his conduct, including without limitation with respect to certain identified information, contrary to ss. 76(3) and/or 76(3.1) of the Health Professions Procedural Code, being Schedule 2 to the Regulated Health Professions Act, 1991.

In particular, it is alleged that he:

  • Failed to maintain a standard of practice of the profession;
  • Practised the profession while in a conflict of interest;
  • Charged a fee or amount that was excessive in relation to the service or product provided;
  • Contravened the Pharmacy Act, the Drug and Pharmacies Regulation Act, the Regulated Health Professions Act, 1991, the Narcotic Safety and Awareness Act, 2010, the Drug Interchangeability and Dispensing Fee Act or the Ontario Drug Benefit Act or the regulations under those acts, and in particular:
    • ss. 76(3) and/or 76(3.1) of the Health Professions Procedural Code, being Schedule 2 to the Regulated Health Professions Act, 1991;
  • Engaged in conduct or performed an act relevant to the practice of pharmacy that, having regard to all the circumstances, would reasonably be regarded by members of the profession as disgraceful, dishonourable or unprofessional.

Hearing Dates: TBA

Summary of Allegations

As a result of a referral by the Inquiries, Complaints and Reports Committee, it is alleged that Abdulmalik Premji, while practising pharmacy as Designated Manager, director and shareholder, and/or dispensing pharmacist at Bay Ridges Pharmacy in Pickering, Ontario, in the period from about October 2018 to July 2019, committed professional misconduct in that he

  • Practised while in a conflict of interest with respect to patient [Name]; and/or
  • Failed to maintain the professional boundaries of the pharmacist-patient relationship with respect to patient [Name].

In particular, it is alleged that he:

  • Failed to maintain a standard of practice of the profession;
  • Practised the profession while in a conflict of interest;
  • Engaged in conduct or performed an act relevant to the practice of pharmacy that, having regard to all the circumstances, would reasonably be regarded by members of the profession as disgraceful, dishonourable or unprofessional.

Hearing Dates: TBA

Summary of Allegations

As a result of a referral by the Inquiries, Complaints and Reports Committee, it is alleged that Rana Rizk, while engaged in the practice of pharmacy as Designated Manager and/or dispensing pharmacist at Westboro Pharmasave in Ottawa, Ontario, committed professional misconduct in that she:

  • Submitted (or permitted, consented to, or approved, expressly or by implication, the submissions of) claims with excessive markups for one or more of certain identified drugs and/or products from in or about November 1, 2016 to in or about April 30, 2018;
  • Submitted (or permitted, consented to, or approved, expressly or by implication, the submissions of) claims to multiple plans where one or more of those plans was not obligated to pay the claim (or the full amount of the claim) for one or more of certain identified drugs and/or products from in or about November 1, 2016 to in or about April 30, 2018; and/or
  • Submitted (or permitted, consented to or approved, expressly or by implication, the submissions of) claims for dispensing fees for compliance packages at more frequent intervals than the compliance packages were being dispensed for one or more patients from in or about May 1, 2018 to in or about April 24, 2019.

In particular, it is alleged that she:

  • Failed to maintain a standard of practice of the profession;
  • Failed to keep records as required respecting her patients and/or practice;
  • Falsified a record relating to her practice and/or a person’s health record;
  • Signed and/or issued, in her professional capacity, a document that she knew and/or ought to have known contained a false and/or misleading statement;
  • Submitted an account and/or charge for services and/or products that she knew and/or ought to have known was false and/or misleading;
  • Charged (or permitted, consented to or approved, expressly or by implication, charges of) a fee and/or amount that was excessive in relation to the service and/or product provided;
  • Engaged in conduct or performed an act relevant to the practice of pharmacy that, having regard to all the circumstances, would reasonably be regarded by members as disgraceful, dishonourable and/or unprofessional.

Hearing Dates: TBA

Summary of Allegations

As a result of a referral by the Inquiries, Complaints and Reports Committee, it is alleged that Rana Rizk, in response to an investigation by the Ontario College of Pharmacists (the “College”) into her conduct at Westboro Pharmasave in Ottawa, Ontario, committed professional misconduct in that she:

  • Provided falsified employment records and/or other pharmacy records to the College;
  • Provided false and/or misleading information to the College in written submissions, emails, and/or other correspondence; and/or
  • Refused to provide relevant documents to College investigators upon request.

In particular, it is alleged that she:

  • Contravened the Regulated Health Professions Act, 1991, as amended, and in particular:
    • Subsections 76(3) and 76(3.1) of the Health Professions Procedural Code to the Regulated Health Professions Act, 1991;
  • Engaged in conduct or performed an act relevant to the practice of pharmacy that, having regard to all the circumstances, would reasonably be regarded by members as disgraceful, dishonourable and/or unprofessional.

Hearing Dates: TBA

Summary of Allegations

As a result of a referral by the Inquiries, Complaints and Reports Committee, it is alleged that George Roufaiel, while engaged in the practice of pharmacy as a Designated Manager and/or dispensing pharmacist at Southdale Pharmacy in London, Ontario, committed professional misconduct in that he

  • Failed to properly complete Destruction Request Forms dated March 6, 2017, November 29, 2016, November 18, 2016 and/or an undated form;
  • Failed to maintain accurate records of purchases, sales and remaining inventory for narcotics, controlled drugs and/or targeted substances;
  • Failed to make timely reports of losses of narcotics, controlled drugs and/or targeted substances to Health Canada during the period March 21, 2015 to April 5, 2017; and/or
  • Failed to take all reasonable steps necessary to protect and secure narcotics, controlled drugs and targeted substances, including:
    • Failing to conduct and/or document narcotic inventory counts including narcotic reconciliations at least every six months during the period March 21, 2015 – March 21, 2017 and/or to maintain the results of the inventory counts for a two-year period;
    • Discrepancies in the inventory of narcotics, controlled drugs and/or targeted substances, as recorded in inventory counts conducted January 20, 2017, March 13, 2017 and/or March 22, 2017; and/or
    • Failing to report the loss, theft or forgery related to narcotics, controlled drugs and/or targeted substances in a timely way to Health Canada following inventory counts on January 20, 2017, March 13, 2017, and/or March 22, 2017.

In particular, it is alleged that he

  • Failed to maintain a standard of practice of the profession;
  • Failed to keep records respecting his patients;
  • Contravened a federal or provincial law or municipal by-law with respect to the distribution, sale or dispensing of any drug or mixture of drugs including:
    • The Narcotic Control Regulations, sections 30, 40, 42 and/or 43, under the Controlled Drugs and Substances Act, S.C. 1996, c. 19; and/or
    • The Food and Drug Regulations, sections G.03.001, G.03.004, G.03.007, G.03.010, G.03.012, G.03.013 and/or G.03.015, under the Food and Drugs Act, R.S.C. 1985 c.F-27;
  • Engaged in conduct or performed an act relevant to the practice of pharmacy that, having regard to all the circumstances, would reasonably be regarded by members of the profession as disgraceful, dishonourable or unprofessional.

 

Hearing Dates: TBA

Summary of Allegations

As a result of a referral by the Inquiries, Complaints and Reports Committee, it is alleged that George Roufaiel, while engaged in the practice of pharmacy as a Designated Manager and/or dispensing pharmacist at Southdale Pharmacy in London, Ontario, committed professional misconduct in that he

  • Failed to sign approximately 55 prescription hardcopies processed on January 3, 2018;
  • Failed to ensure that a stock bottle contained only one brand of alprazolam 0.5 mg on January 15, 2018;
  • Failed to take all reasonable steps necessary to protect and secure narcotics, controlled drugs and/or targeted substances during the period March 23, 2017 to January 30, 2018, including:
    • Discrepancies in the inventory of narcotics, controlled drugs and/or targeted substances, as recorded in inventory counts conducted October 2, 2017, October 27, 2017, November 30, 2017, an unknown date, and/or January 15, 2018;
    • Failing to conduct narcotic inventory counts including narcotic reconciliations at least every six months and/or to maintain the results of the inventory counts for a two-year period;
    • Failing to maintain accurate records as required of purchases, sales and remaining inventory for narcotics, controlled drugs and/or targeted substances; and/or
    • Failing to make timely reports of destruction or losses of narcotics, controlled drugs and/or targeted substances to Health Canada.

In particular, it is alleged that he

  • Failed to maintain a standard of practice of the profession
  • Failed to keep records as required respecting his patients and/or practice
  • Contravened any federal, provincial or territorial law or municipal by-law with respect to the distribution, purchase, sale, or dispensing or prescribing of any drug or product, the administering of any substance, or the piercing of the dermis, whose purpose is to protect or promote public health or that is otherwise relevant to his suitability to practise including
    • The Narcotic Control Regulations, sections 30, 40, 42 and/or 43, under the Controlled Drugs and Substances Act, S.C. 1996, c. 19; and/or
    • The Food and Drug Regulations, sections G.03.001, G.03.004, G.03.007, G.03.010, G.03.012, G.03.013 and/or G.03.015, under the Food and Drugs Act, R.S.C. 1985 c.F-27; and/or
  • Engaged in conduct or performed an act relevant to the practice of pharmacy that, having regard to all the circumstances, would reasonably be regarded by members of the profession as disgraceful, dishonourable or unprofessional.

 

Hearing Dates: TBA

Summary of Allegations

As a result of a referral by the Inquiries, Complaints and Reports Committee, it is alleged that Sameh Sadek, while engaged in the practice of pharmacy as a Designated Manager and/or dispensing pharmacist at MD Health Pharmacy in Brampton, Ontario (the “Pharmacy”), and/or as a director and/or shareholder of the corporation that owned and/or operated the Pharmacy, committed professional misconduct in that:

  • He failed to report to the Registrar the details of being charged on or about February 22, 2017 with the offence of refusing to comply with a demand for a breath sample contrary to s. 254(5) of the Criminal Code of Canada;
  • He failed to report to the Registrar the details of being charged on or about March 27, 2018 with the offence of assaulting a peace officer contrary to s. 270(1)(a) of the Criminal Code of Canada;
  • On or about March 8, 2018, he declared to the College as part of his annual renewal process that he was not currently charged with a criminal offence or any other offence in Ontario or any other jurisdiction, when at that time he was charged with the offence of refusing to comply with a demand for a breath sample contrary to s. 254(5) of the Criminal Code of Canada;
  • Between about June 1, 2017 and February 20, 2018, he submitted (or permitted, consented to or approved, expressly or impliedly, the submission of) claims, charges and/or accounts for drugs that were not dispensed, and/or that were for invalid prescriptions, with respect to certain identified drugs;
  • On or about April 27, 2018 and in the period following that date, he closed the Pharmacy without complying with the requirements for closing a Pharmacy, and in particular:
    • he failed to remove all signs and symbols relating to the practice of pharmacy from within and outside the premises;
    • he failed to remove and dispose of all drugs according to law;
    • he failed to submit to the Registrar a Pharmacy Closing Statement;
    • he failed to deliver prescription records;
    • he failed to ensure the Pharmacy’s records were maintained in a secure manner and for the required period of time;
  • On or about June 13, 2018, July 4, 2018, and July 19, 2018, he failed to reply within a reasonable time to requests from the College relating to the closure of the Pharmacy.

In particular, it is alleged that he:

  • Contravened a term, condition or limitation on his certificate of registration;
  • Failed to maintain a standard of practice of the profession;
  • Falsified a record relating to his practice or a person’s health record;
  • Signed or issued, in his professional capacity, a document that he knew or ought to have known contained a false or misleading statement;
  • Submitted an account or charge for services or products that he knew or ought to have known contained a false or misleading statement;
  • Contravened the Pharmacy Act, the Drug and Pharmacies Regulation Act, the Regulated Health Professions Act, 1991, the Narcotic Safety and Awareness Act, 2010, the Drug Interchangeability and Dispensing Fee Act or the Ontario Drug Benefit Act or the regulations under those acts, and in particular:
    • s. 141 and s. 157(2) of the Drug and Pharmacies Regulation Act, RSO 1990, c. H.4;
    • ss. 20(2) and 21 of O. Reg. 264/16 made under the Drug and Pharmacies Regulation Act, RSO 1990, c. H.4;
  • Failed to reply within a reasonable time to a written or electronic inquiry or request from the College;
  • Engaged in conduct or performed an act relevant to the practice of pharmacy that, having regard to all the circumstances, would reasonably be regarded by members of the profession as disgraceful, dishonourable or unprofessional.

Hearing Dates: TBA

Summary of Allegations

As a result of a referral by the Inquiries, Complaints and Reports Committee, it is alleged that Mr. Saleh committed professional misconduct in that

  • On or about September 14, 2017, he committed Sexual Assault, contrary to section 271 of the Criminal Code of Canada, for which he was found criminally guilty on March 6, 2019.

In particular, it is alleged that he

  • Has been found guilty of an offence that is relevant to his suitability to practice;
  • Engaged in conduct that is unbecoming a member.

 

Hearing Dates: TBA

Summary of Allegations

As a result of a referral by the Inquiries, Complaints and Reports Committee, it is alleged that Mr. Hani Salib, while engaged in the practice of pharmacy as Designated Manager and/or dispensing pharmacist at Queentario Pharmacy in Mississauga, Ontario (the “Pharmacy”), and/or as a director and/or shareholder of the corporation that owned and/or operated the Pharmacy, committed professional misconduct in that

  • Between about June 1, 2014 and November 1, 2016, he created (or permitted, consented to or approved, expressly or impliedly, the creation of) false and/or misleading pharmacy records documenting the dispensing of certain identified drugs and/or products that were not dispensed;
  • Between about June 1, 2014 and November 1, 2016, he submitted (or permitted, consented to or approved, expressly or impliedly, the submission of) charges for certain identified drugs and/or products that were not dispensed;
  • Between about June 1, 2014 and November 1, 2016, he introduced into active inventory (or permitted, consented to or approved, expressly or impliedly, the introduction into active inventory of) certain identified drugs and/or products that were acquired from unauthorized and/or improper sources;
  • Between about July 28, 2015 and November 4, 2016, he failed to discover and/or report a loss or theft of narcotics with respect to Oxycodone CR 40mg;
  • Between about July 28, 2015 and November 4, 2016, he failed to perform and/or maintain accurate inventory counts and/or reconciliations of narcotics; and/or
  • He dispensed a prescription for Oxycodone CR 80mg in doses and/or quantities that were clinically questionable, without taking and/or documenting appropriate and/or sufficient steps to assess the propriety of the prescription, on or about the following dates:
    • January 10, 2014
    • April 15, 2014
    • July 14, 2014
    • October 15, 2014
    • January 5, 2015
    • April 16, 2015
    • July 10, 2015

In particular, it is alleged that he

  • Failed to maintain a standard of practice of the profession
  • Falsified a record relating to his practice
  • Submitted an account or charge for services that he knew was false or misleading
  • Contravened a federal or provincial law or municipal by-law with respect to the distribution, sale or dispensing of any drug or mixture of drugs, and in particular:
    • s. 42 of the Narcotic Control Regulations, CRC c 1041, made under the Controlled Drugs and Substances Act, SC 1996, c 19
  • Returned to stock or again sold or dispensed a drug previously sold or dispensed and delivered
  • Engaged in conduct or performed an act relevant to the practice of pharmacy that, having regard to all the circumstances, would reasonably be regarded by members of the profession as disgraceful, dishonourable or unprofessional

Hearing Dates: TBA

Summary of Allegations

As a result of a referral by the Inquiries, Complaints and Reports Committee, it is alleged that Lalit Satija, while engaged in the practice of pharmacy as director, shareholder, owner, designated manager, and/or dispensing pharmacist at Medicare Pharmacy in Oakville, Ontario (“Medicare Oakville”), and/or director, shareholder, owner, designated manager, and/or dispensing pharmacist at Medicare Pharmacy in Brampton, Ontario (“Medicare Brampton”), committed professional misconduct in that he:

  • Failed to conduct, and/or maintain a record of, adequate inventory counts and/or reconciliations for narcotics and/or other controlled substances and/or to report losses to Health Canada as required from in or about January 2017 to in or about December 2018;
  • Submitted false claims, falsified records, and/or failed to keep records as required with respect to approximately 51 claims for MedsCheck reviews between in or about November 2017 and in or about December 2018;
  • Submitted claims for dispensing fees for compliance packages at more frequent intervals than the compliance packages were being dispensed for one or more patients from in or about January 2018 to in or about March 2019;
  • Failed to dispose of expired medications and/or failed to have adequate systems in place to ensure expired medications were removed from stock from in or about August 2018 to in or about December 2018;
  • Returned to stock, resold, and/or re-dispensed a drug that was previously sold or dispensed, with respect to one or more of certain identified prescriptions from in or about July 2017 to in or about March 2019;
  • Failed to cancel prescriptions that were returned to stock, resold, and/or re-dispensed, with respect to one or more of certain identified prescriptions from in or about July 2017 to in or about March 2019;
  • Dispensed medications without accurately recording the Drug Identification Number and/or the identity of the manufacturer on the prescription hardcopy, label, and/or in the pharmacy’s electronic records from in or about July 2018 to in or about December 2018;
  • Requested, accepted, and/or failed to repay loans to patients from in or about 2012 to in or about 2019; and/or
  • Charged the credit card of a patient without the patient’s authorization from in or about December 2012 to in or about March 2017.

In particular, it is alleged that he:

  • Failed to maintain a standard of practice of the profession;
  • Practised the profession while in a conflict of interest;
  • Failed to keep records as required respecting his patients and/or practice;
  • Falsified a record relating to his practice and/or a person’s health record;
  • Signed or issued, in his professional capacity, a document that he knew and/or ought to have known contained a false or misleading statement;
  • Submitted an account or charge for services or products that he knew and/or ought to have known was false or misleading;
  • Contravened a federal, provincial or territorial law with respect to the distribution, sale or dispensing of any drug or mixture of drugs, with respect to the distribution, purchase, sale, dispensing or prescribing of any drug or product, the administering of any substance, or the piercing of the dermis, whose purpose is to protect or promote the public health, and/or that is otherwise relevant to his suitability to practise, and in particular:
    • sections 42 and/or 43 of the Narcotic Control Regulations, as amended, and/or
    • section 7 of the Benzodiazepines and Other Targeted Substances Regulations, as amended;
  • Returned to stock, resold, and/or re-dispensed a drug that was previously sold or dispensed;
  • Engaged in conduct or performed an act relevant to the practice of pharmacy that, having regard to all the circumstances, would reasonably be regarded by members as disgraceful, dishonourable or unprofessional.

Hearing Dates: TBA

Summary of Allegations

As a result of a referral by the Inquiries, Complaints and Reports Committee, it is alleged that Kaushil Shah, as staff pharmacist and/or Designated Manager at Pharma Centre Pharmacy in Toronto, Ontario, committed professional misconduct in that he:

  • Sold by retail and/or dispensed prescription drugs to patients in the U.S. without a lawful and/or otherwise valid prescription;
  • Contravened the OCP Policy on Prescriptions-Out of Country, dated January-February 2003; and/or
  • Falsified records to indicate prescription drugs were being sold by retail and/or dispensed to patients in the U.S. pursuant to a lawful and/or otherwise valid prescription when no such authorization had been provided.

In particular, it is alleged that he:

  • Failed to maintain a standard of practice of the profession;
  • Falsified a record relating to his practice;
  • Signed or issued, in his professional capacity, a document that he knew contained a false or misleading statement;
  • Contravened the Act, the Drug and Pharmacies Regulation Act, the Regulated Health Professions Act, 1991, or the regulations under those Acts, and in particular, sections 155 and/or 158 of the Drug and Pharmacies Regulation Act, R.S.O. 1990, c. H-4, as amended;
  • Contravened, while engaged in the practice of pharmacy, any federal or provincial law or municipal by-law with respect to the distribution, sale or dispensing of any drug or mixture of drugs, and in particular, sections C.01.041 and/or C.01.042 of the Food and Drug Regulations, C.R.C., c. 870, as amended;
  • Engaged in conduct or performed an act relevant to the practice of pharmacy that, having regard to all circumstances, would reasonably be regarded by members as disgraceful, dishonourable or unprofessional.

Hearing Dates: TBA

Summary of Allegations

As a result of a referral by the Inquiries, Complaints and Reports Committee, it is alleged that Shirish Shah, as staff pharmacist at Pharma Centre Pharmacy in Toronto, Ontario, (“Pharmacy”), and/or as sole director and majority shareholder of the corporation that owned the Pharmacy, committed professional misconduct in that he:

  • Sold by retail and/or dispensing prescription drugs to patients in the U.S. without a lawful and/or otherwise valid prescription;
  • Contravened the OCP Policy on Prescriptions-Out of Country, dated January-February 2003; and/or
  • Falsified records to indicate prescription drugs were being sold by retail and/or dispensed to patients in the U.S. pursuant to a lawful and/or otherwise valid prescription when no such authorization had been provided.

In particular, it is alleged that he:

  • • Failed to maintain a standard of practice of the profession;
  • Falsified a record relating to his practice;
  • Signed or issued, in his professional capacity, a document that he knew contained a false or misleading statement;
  • Contravened the Pharmacy Act, the Drug and Pharmacies Regulation Act, the Regulated Health Professions Act, 1991, or the regulations under those Acts, and in particular, sections 155 and/or 158 of the Drug and Pharmacies Regulation Act, R.S.O. 1990, c. H-4, as amended;
  • Contravened, while engaged in the practice of pharmacy, any federal or provincial law or municipal by-law with respect to the distribution, sale or dispensing of any drug or mixture of drugs, and in particular, sections C.01.041 and/or C.01.042 of the Food and Drug Regulations, C.R.C., c. 870, as amended;
  • Engaged in conduct or performed an act relevant to the practice of pharmacy that, having regard to all circumstances, would reasonably be regarded by members as disgraceful, dishonourable or unprofessional.

Hearing Dates: TBA

Summary of Allegations

As a result of a referral by the Inquiries, Complaints and Reports Committee, it is alleged that Mr. Shaheen while engaged in the practice of pharmacy as director, shareholder, Designated Manager and/or dispensing pharmacist in Ottawa, Ontario, committed professional misconduct in that he

  • Engaged in the trafficking of controlled substance with respect to certain identified items
  • Dispensed drugs and/or products for which prescriptions are legislatively required without an authorized prescriber’s authorization as set out for certain identified items
  • In or about the period from January 2013 to March 2015, he failed to keep records as required by the Medication Procurement and Inventory Management Policy with respect to the inventory of narcotics and controlled drugs
  • Submitted accounts or charges for services that he knew were false or misleading to the Ontario Drug Benefit program for one or more certain identified drugs and/or drug products
  • Falsified pharmacy records relating to his practice in relation to claims made to the Ontario Drug Benefit program for one or more certain identified drugs and/or drug products
  • From approximately January 2013 to March 2015, he used his position as pharmacist to traffic in narcotics, in particular fentanyl patches
  • Procured an individual to carry out a simulated robbery of the IDA Rideau Pharmacy on October 26, 2014
  • Made a report to the […] Police in respect of a robbery allegedly committed on October 26, 2014, knowing that the report was false

In particular, it is alleged that he

  • Failed to maintain a standard of practice of the profession
  • Failed to keep records as required respecting his patients
  • Signed or issued, in his professional capacity, a document that he knew contained a false or misleading statement with respect to the certain identified forged prescriptions
  • Submitted accounts or charges for services that he knew to be false or misleading
  • Contravened the Act, the Drug and Pharmacies Regulation Act, the Regulated Health Professions Act, 1991 or the regulations under those Acts with respect to the following incidents:
    • Dispensing drugs and/or products in the absence of a prescription authorized by a prescriber in contravention of s. 40 of Ontario Regulation 58/11 under the Drug and Pharmacies Regulation Act and ss. 155 and 156
  • Contravened, while engaged in the practice of pharmacy, a federal or provincial law or municipal by-law with respect to the distribution, sale or dispensing of any drug or mixture of drugs, and in particular, and in particular, with respect to the following incidents:
    • Trafficking controlled substances in contravention of s. 5 of the Controlled Drugs and Substances Act
    • Dispensing drugs in the absence of a prescription authorized by a prescriber in contravention of s. 31 of the Narcotic Control Regulation
    • Selling drugs in the absence of a prescription authorized by a prescriber in contravention of C.01.041 of the Food and Drug Regulations
    • Selling drugs in the absence of a prescription authorized by a prescriber in contravention of G.03.002 of the Food and Drug Regulations
  • Knowingly permitted the premises in which the pharmacy was located to be used for unlawful purposes
  • Permitted, consented to or approved, either expressly or by implication, the commission of an offence against any Act relating to the practice of pharmacy or to the sale of drugs by a corporation of which he was a director
  • Engaged in conduct or performed an act relevant to the practice of pharmacy that, having regard to all the circumstances, would reasonably be regarded by members of the profession as disgraceful, dishonourable or unprofessional

Hearing Dates: TBA

Summary of Allegations

As a result of a referral by the Inquiries, Complaints and Reports Committee, it is alleged that Mr. Shaheen committed professional misconduct in that he

  • Failed to comply with the decision of the Inquiries, Complaints and Reports Committee dated May 10, 2016, in that he failed to successfully complete the Professional Problem-Based Ethics workshop offered by the Center for Personalized Education for Physicians, at his own expense, within 12 months of the date of that decision, and provide proof thereof to the College.

In particular, it is alleged that he

  • Failed to maintain a standard of practice of the profession
  • Contravened the Act, the Drug and Pharmacies Regulation Act, the Regulated Health Professions Act, 1991 or the regulations under those Acts, namely: he contravened s. 26(3) of the Health Professions Procedural Code
  • Engaged in conduct or performed an act relevant to the practice of pharmacy that, having regard to all the circumstances, would reasonably be regarded by members of the profession as disgraceful, dishonourable or unprofessional

Hearing Dates: TBA

Summary of Allegations

As a result of a referral by the Inquiries, Complaints and Reports Committee, it is alleged that Mr. Shaheen, while engaged in the practice of pharmacy as dispensing pharmacist, Designated Manager, shareholder and/or director at IDA Rideau Medical Pharmacy in Ottawa, Ontario, between May 2, 2011 and June 17, 2015, committed professional misconduct in that he

  • Falsified pharmacy records relating to his practice in connection with claims made for certain identified drugs and/or other products and/or certain identified MedsCheck claims;
  • Signed or issued, in his professional capacity, a document that he knew contained a false or misleading statement in connection with claims made for certain identified drugs and/or other products and/or certain identified MedsCheck claims;
  • Submitted an account or charge for services that he knew was false or misleading in connection with claims made for certain identified drugs and/or other products and/or certain identified MedsCheck claims

In particular, it is alleged that he

  • Failed to maintain a standard of practice of the profession
  • Falsified pharmacy records relating to his practice
  • Signed or issued, in his professional capacity, a document that he knew contained a false or misleading statement
  • Submitted an account or charge for services that he knew was false or misleading
  • Contravened a federal or provincial law or municipal by-law with respect to the distribution, sale or dispensing of any drug or mixture of drugs, and in particular, sections 5, 6 and 15(1) of the Ontario Drug Benefit Act, R.S.O. 1990, c. O.10, as amended
  • Engaged in conduct or performed an act relevant to the practice of pharmacy that, having regard to all the circumstances, would reasonably be regarded by members of the profession as disgraceful, dishonourable or unprofessional

Hearing Dates: TBA

Summary of Allegations

As a result of a referral by the Inquiries, Complaints and Reports Committee, it is alleged that Mourcos Shenouda, as a pharmacist and Designated Manager at Upper Ottawa Pharmacy (the Pharmacy), in Hamilton, Ontario, and/or as director and/or shareholder of the corporation that owns and operates the Pharmacy, committed professional misconduct in that he billed for the weekly dispensing of medication in compliance aids to patients when he in fact dispensed in longer intervals to those patients, thereby charging a greater total dispensing fee than that to which he was entitled, and thereby maintaining inaccurate records of the dates on which drugs and/or products were dispensed, with respect to certain identified patients identified, from on or about June 27, 2017, to on or about July 4, 2019.

In particular, it is alleged that he:

  • Failed to maintain a standard of practice of the profession;
  • Failed to keep records as required respecting his patients or practice;
  • Falsified a record related to his practice or a person’s health record;
  • Signed or issued in his professional capacity, a document that he knew or ought to have known contained a false or misleading statement;
  • Submitted an account or charge for services or products that he knew or ought to have known was false or misleading;
  • Engaged in conduct or performed an act relevant to the practice of pharmacy that, having regard to all the circumstances, would reasonably be regarded by members as disgraceful, dishonourable or unprofessional.

Hearing Dates: TBA

Summary of Allegations

As a result of a referral by the Inquiries, Complaints and Reports Committee, it is alleged that Mr. Syed, as dispensing pharmacist and/or Designated Manager at MobilRx in Lynden, Ontario (“the Pharmacy”), and/or as director and shareholder of the corporation that owns the Pharmacy, committed professional misconduct, in or about January-February 2018, in that he:

  • Dispensed less than the full quantity of the drug prescribed for the patient, [Patient 1], without the consent of the patient or other authorization, notification to the prescriber and/or documentation of any valid reason for doing so, as required;
  • Charged excessive dispensing fees for dispensing the drug prescribed for the patient, [Patient 1], on a daily basis rather than the full quantity prescribed, without the consent of the patient or other authorization, notification to the prescriber and/or documentation of any valid reason for doing so; and/or
  • Entered into an arrangement with [Person A], the manager of [Facility], requiring residents, including the patient, [Patient 1], to accept prescription services from the Pharmacy and/or for all prescriptions to be filled on a daily basis.

In particular, it is alleged that he:

  • Failed to maintain the standard of practice of the profession;
  • Failed to provide an appropriate level of supervision to a person whom he was professionally obligated to supervise;
  • Submitted an account or charge for services or products that he knew or ought to have known was false or misleading;
  • Charged a fee or amount that was excessive in relation to the service or product provided;
  • Entered into an agreement that restricted a person’s choice of a pharmacist without the consent of the person;
  • Contravened the Act, the Drug and Pharmacies Regulation Act, the Regulated Health Professions Act, 1991, the Narcotics Safety and Awareness Act, 2010, the Drug Interchangeability and Dispensing Fee Act or the Ontario Drug Benefit Act or the regulations under those Acts, and in particular,
    • sections 5 and/or 6 of the Ontario Drug Benefit Act, R.S.O. 1990, c.O.10, as amended, and/or
    • sections 18 and/or 27 of Ontario Regulation 201/96, as amended;
  • Engaged in conduct or performed an act relevant to the practice of pharmacy that, having regard to all the circumstances, would reasonably be regarded by members as disgraceful, dishonourable or unprofessional;
  • Engaged in conduct that is unbecoming a member.

 

Hearing Dates: TBA

Summary of Allegations

As a result of a referral by the Inquiries, Complaints and Reports Committee, it is alleged that Mr. Syed, as dispensing pharmacist and/or Designated Manager at MobilRx in Lynden, Ontario (“the Pharmacy”), and/or as director and shareholder of the corporation that owns the Pharmacy, committed professional misconduct, in or about February-May 2018, in that he

  • Dispensed less than the full quantities of drugs prescribed for the patient, [Patient], without the consent of the patient or other authorization, notification to the prescriber and/or documentation of any valid reason for doing so, as required;
  • Charged excessive dispensing fees for dispensing the drugs prescribed for the patient, [Patient], on a daily basis rather than the full quantities prescribed, without the consent of the patient or other authorization, notification to the prescriber and/or documentation of any valid reason for doing so; and/or
  • Entered into an arrangement with [Person A], the manager of [Facility], requiring residents, including the patient, [Patient], to accept prescription services from the Pharmacy and/or for all prescriptions to be filled on a daily basis.

 

In particular, it is alleged that he

  • Failed to maintain the standard of practice of the profession;
  • Failed to provide an appropriate level of supervision to a person whom he was professionally obligated to supervise;
  • Submitted an account or charge for services or products that he knew or ought to have known was false or misleading;
  • Charged a fee or amount that was excessive in relation to the service or product provided;
  • Entered into an agreement that restricted a person’s choice of a pharmacist without the consent of the person;
  • Contravened the Act, the Drug and Pharmacies Regulation Act, the Regulated Health Professions Act, 1991, the Narcotics Safety and Awareness Act, 2010, the Drug Interchangeability and Dispensing Fee Act or the Ontario Drug Benefit Act or the regulations under those Acts, and in particular,
    • sections 5 and/or 6 of the Ontario Drug Benefit Act, R.S.O. 1990, c.O.10, as amended, and/or
    • sections 18 and/or 27 of Ontario Regulation 201/96, as amended;
  • Engaged in conduct or performed an act relevant to the practice of pharmacy that, having regard to all the circumstances, would reasonably be regarded by members as disgraceful, dishonourable or unprofessional;
  • Engaged in conduct that is unbecoming a member.

 

Hearing Dates: TBA

Summary of Allegations

As a result of a referral by the Inquiries, Complaints and Reports Committee, it is alleged that Kochupalanilkunnathil Varghese, while engaged in the practice of pharmacy as director, shareholder, Designated Manager and/or dispensing pharmacist at Eglinton Discount Drugs (the “Pharmacy”, committed professional misconduct in that he

  • Charged third party payers for drugs not dispensed, for one or more of certain identified drugs, from on or about May 1, 2017 to on or about June 1, 2019;
  • Submitted and/or permitted, consented to or approved, either expressly or by implication, the submission of accounts or charges that he knew were false or misleading to the Ontario Drug Benefit program, [Claims Adjudicator A] and/or [Claims Adjudicator B] through the Pharmacy, for one or more of certain identified drugs, from on or about May 1, 2017 to on or about June 1, 2019;
  • Falsified and/or permitted, consented to or approved, either expressly or by implication, the falsification of pharmacy records relating to his practice in relation to the dispensing of and/or claims made through the Ontario Drug Benefit program, [Claims Adjudicator A] and/or [Claims Adjudicator B] through the Pharmacy, for one or more of certain identified drugs, from on or about May 1, 2017 to on or about June 1, 2019;
  • Signed or issued in his professional capacity, and/or permitted, consented to or approved, either expressly or by implication, the signing or issuing of a document that he knew or ought to have known contained a false or misleading statement including documents in relation to the dispensing of and/or claims made through the Ontario Drug Benefit program, [Claims Adjudicator A] and/or [Claims Adjudicator B] through the Pharmacy, for one or more of certain identified drugs, from on or about May 1, 2017 to on or about June 1, 2019;
  • Submitted an account or charge for services or products that he knew or ought to have known was false or misleading with respect to claims made through the Ontario Drug Benefit program, [Claims Adjudicator A] and/or [Claims Adjudicator B] through the Pharmacy, for one or more of certain identified drugs, from on or about May 1, 2017 to on or about June 1, 2019;
  • Charged a fee or amount that is excessive in relation to the service or product provided, with respect to claims made through the Ontario Drug Benefit program, [Claims Adjudicator A] and/or [Claims Adjudicator B] through the Pharmacy, for one or more of certain identified drugs, from on or about May 1, 2017 to on or about June 1, 2019;
  • Failed to ensure that the Pharmacy complied with all legal and professional requirements, including but not limited to requirements regarding record keeping, documentation, and billing the Ontario Drug Benefit program, [Claims Adjudicator A] and/or [Claims Adjudicator B], from on or about May 1, 2017 to on or about June 1, 2019; and/or
  • Repeatedly dispensed more than 30 tablets or capsules for a one month supply of medication, including but not limited to patients [A], [B], [C], [D], [E] and [F], contrary to the NAPRA Model Standards of Practice for Canadian Pharmacists which require pharmacists to ensure that quantities dispensed are correct.

In particular, it is alleged that he:

  • Failed to maintain a standard of practice of the profession;
  • Failed to keep records as required respecting his patients or practice;
  • Falsified a record relating to his practice or a person’s health record;
  • Signed or issued, in his professional capacity, a document that he knew or ought to have known contained a false or misleading statement;
  • Submitted an account or charge for services or products that he knew or ought to have known was false or misleading;
  • Charged a fee or amount that was excessive in relation to the service or product provided;
  • Contravened the Pharmacy Act, the Drug and Pharmacies Regulation Act, the Regulated Health Professions Act, 1991, the Narcotics Safety and Awareness Act, 2010, the Drug Interchangeability and Dispensing Fee Act or the Ontario Drug Benefit Act or the regulations under those Acts, in particular but not limited to:
    • sections 155 and 156 of the Drug and Pharmacies Regulation Act; and/or
    • sections 5, 6 and 15 of the Ontario Drug Benefit Act;
  • Contravened any federal, provincial or territorial law or municipal by-law, i. with respect to the distribution, purchase, sale, or dispensing or prescribing of any drug or product, the administering of any substance, or the piercing of the dermis, ii. whose purpose is to protect or promote public health, or iii. that is otherwise relevant to the member’s suitability to practise, in particular but not limited to:
    • sections 155 and 156 of the Drug and Pharmacies Regulation Act; and/or
    • sections 5, 6 and 15 of the Ontario Drug Benefit Act;
  • Permitted, consented to, approved, counselled or assisted, whether expressly or by implication, the commission of an offence against any Act relating to the practice of pharmacy or the sale of drugs, in particular but not limited to:
    • sections 155 and 156 of the Drug and Pharmacies Regulation Act; and/or
    • sections 5, 6 and 15 of the Ontario Drug Benefit Act;
  • Engaged in conduct or performed an act relevant to the practice of pharmacy that, having regard to all the circumstances, would reasonably be regarded by members as disgraceful, dishonourable or unprofessional.

Hearing Dates: TBA

Summary of Allegations

As a result of a referral by the Inquiries, Complaints and Reports Committee, it is alleged that Hong Hong Xie, as the dispensing pharmacist at Healthpoint Pharmacy in Unionville, committed professional misconduct in that she:

  • Failed to adequately review narcotic prescriptions being dispensed to patients for the first time and to perform adequate patient assessments to ensure that the medication(s) being dispensed was appropriate;
  • Failed to adequately document patient assessments (if any) before dispensing narcotic prescriptions to patients for the first time to ensure that the medication(s) being dispensed was appropriate contrary to the Ontario College of Pharmacists’ Documentation Guidelines;
  • Failed to document pertinent discussions with other pharmacies and prescribers after receiving Drug Utilization Review warning response codes from the Narcotics Monitoring System, and accordingly, failed to comply with the Ontario College of Pharmacists’ Documentation Guidelines on the following occasions:
    1. On or around October 1, 2018 with respect to prescription #[number];
    2. On or around October 4, 2018 with respect to prescription #[number]; and
    3. On or around October 4, 2018 with respect to prescription #[number]
  • Failed to record her assessments (if any) of the appropriateness of dispensing narcotics prescribed by physician Dr. [Name] between approximately October 1, 2018 to November 19, 2018;
  • Failed to record a patient identification number before dispensing a narcotic prescription with respect to prescription #[number];
  • Engaged in the practice of pharmacy without keeping accurate and/or complete records as required; and
  • Failed to perform adequate assessments before dispensing narcotics to a high volume of patients between approximately October 1, 2018 and November 19, 2018

In particular, it is alleged that she:

  • Failed to maintain standards of practice of the profession;
  • Failed to keep records and/or documentation with respect to her patients and/or practice; and
  • Engaged in conduct or performed acts that, having regard to all the circumstances, would reasonably be regarded by members of the profession as unprofessional, dishonourable or disgraceful.

Hearing Dates: TBA

Summary of Allegations

As a result of a referral by the Inquiries, Complaints and Reports Committee, it is alleged that Li Ping Zhang, as the Designated Manager and/or dispensing pharmacist at Healthpoint Pharmacy in Unionville, committed professional misconduct in that:

  • She failed to adequately review narcotic prescriptions being dispensed to patients for the first time and to perform adequate patient assessments to ensure that the medication(s) being dispensed was appropriate;
  • She failed to adequately document patient assessments (if any) before dispensing narcotic prescriptions to patients for the first time to ensure that the medication(s) being dispensed was appropriate contrary to the Ontario College of Pharmacists’ Documentation Guidelines;
  • As the Designated Manager, she failed to ensure that appropriate risk assessment and management systems were in place within a high volume and high risk narcotic dispensing practice, contrary to the Ontario College of Pharmacists’ policy Designated Manager – Professional Supervision of Pharmacy Personnel.
  • She failed to document pertinent discussions with other pharmacies and prescribers after receiving Drug Utilization Review warning response codes from the Narcotics Monitoring System, and accordingly, failed to comply with the Ontario College of Pharmacists’ Documentation Guidelines on the following occasions:
    1. On or around October 3, 2018 with respect to prescription #[number];
    2. On or around October 5, 2018 with respect to prescription #[number];
    3. On or around October 10, 2018 with respect to prescription #[number]; and
    4. On or around October 30, 2018 with respect to prescription #[number]
  • She failed to record her assessments (if any) of the appropriateness of dispensing narcotics prescribed by physician Dr. [Name] between approximately October 1, 2018 to November 19, 2018;
  • She engaged in the practice of pharmacy without keeping accurate and/or complete records as required; and
  • She failed to perform adequate assessments before dispensing narcotics to a high volume of patients between approximately October 1, 2018 and November 19, 2018.

In particular, it is alleged that she:

  • Failed to maintain standards of practice of the profession;
  • Failed to keep records and/or documentation with respect to her patients and/or practice;
  • Engaged in conduct or performed acts that, having regard to all the circumstances, would reasonably be regarded by members of the profession as unprofessional, dishonourable or disgraceful.